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ABSTRACT 
 
SbmA/BacA is a protein of the inner membrane of many Gram negative bacteria, predicted to be 
the transmembrane domain of an ABC transport system. sbmA-deleted E. coli strain shows an 
increased resistance to the antimicrobial peptide Bac7 and other proline-rich peptides due to their 
reduced uptake. In addition, BacA of some Gram negative species is essential to establish chronic 
infection in animal and plant hosts.  
The aim of this study was to characterize the architecture and function of the SbmA transport 
system in E. coli.  
By affinity chromatography and fluorescence anisotropy assays we showed that SbmA is able to 
bind Bac7 also without the requirement of a substrate-binding protein. By using a bacterial two-
hybrid BACTH system and in vitro crosslinking assay we showed that SbmA forms dimers both in 
vivo and in vitro. Flow cytometry analysis using different metabolic inhibitors indicate that the 
proton motive force rather than ATP hydrolysis may represent the driving force for the translocation 
of peptide substrates.  
Searching for possible interactors of SbmA, we showed that the yaiW gene, located downstream of 
sbmA, is part of the same operon. Even if the two genes are cotranscribed, the corresponding 
proteins do not seem to interact neither at the cytoplasmic nor at the inner membrane level. 
However, ∆yaiW strain showed an increased resistance to Bac7 suggesting the involvement of this 
protein in the SbmA-mediated uptake of the peptide.  
An in vivo screening of the whole proteome of E. coli against SbmA by the BACTH system did not 
identify any nucleotide-binding domain of the transporter, strengthening the hypothesis that the 
transport system is energized by a mechanism different from ATP hydrolysis. Two-hybrid analysis 
allowed us to fish out 9 potential interactors and among those our attention was focused on FieF, an 
inner membrane protein involved in zinc efflux from the bacterial cell.  
We demonstrated that FieF is involved in the SbmA-mediated uptake of Bac7 and that the 
expression of sbmA is modulated by zinc ions in a complex manner, suggesting a stress role for this 
protein in bacteria.  
Overall, these findings suggest that SbmA is an unusual peptide transporter likely derived from the 
widespread ABC transporters, which has evolutionary lost/changed some typical features of this 
transport systems, such as the request of a substrate-binding protein and the ATP binding domain.  
The interaction between SbmA and FieF points to a possible involvement of the former in zinc 
detoxification, a function which may be modulated by the binding of an unidentified peptide 
substrate. The regulation of the expression of SbmA by zinc ions might have a physiological 
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relevance in the host because it makes the target bacteria more susceptible to the AMPs and 
activates cellular effectors such as the neutrophils. 
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RIASSUNTO 
 
SbmA/BacA è una proteina della membrana interna presente nei batteri Gram negativi e 
caratterizzata da omologia di sequenza con i domini transmembrana (TMDs) dei sistemi di trasporto 
di tipo ABC. Ceppi di E. coli con una delezione completa del gene sbmA mostrano un’aumentata 
resistenza al peptide antimicrobico Bac7 e ad altri peptidi ricchi in prolina a seguito di una loro 
ridotta internalizzazione. Gli omologhi di SbmA in altre specie sono essenziali per instaurare 
un’infezione cronica sia in ospiti di origine vegetale che animale.  
Lo scopo del presente lavoro è stato caratterizzare l’organizzazione e la funzione del sistema di 
trasporto rappresentato da SbmA in E. coli.  
Mediante saggi di cromatografia di affinità e di anisotropia a fluorescenza, è stato mostrato come 
SbmA sia in grado di legare Bac7 senza la necessità di una proteina di legame del substrato (SBP). 
Inoltre, mediante la tecnica del doppio ibrido in batterio e saggi di crosslinking in vitro, è stato 
mostrato come SbmA formi dimeri sia in vivo sia in vitro. Saggi di citofluorimetria in presenza di 
diversi inibitori metabolici indicano come la presenza di un gradiente protonico sia essenziale per 
garantire il trasporto del peptide attraverso la membrana batterica, trasporto che sembra essere 
indipendente dall’energia derivata dall’idrolisi dell’ATP.  
Allo scopo di identificare possibili interattori di SbmA, è stato analizzato il locus genomico di sbmA 
ed è stato dimostrato che il gene yaiW, localizzato a valle di sbmA, forma con quest’ultimo un’unica 
unità trascrizionale. Sebbene i due geni siano cotrascritti, le corrispondenti proteine non sembrano 
interagire né a livello citoplasmatico né di membrana interna. Tuttavia, l’interazione tra queste due 
proteine a livello periplasmico non può essere esclusa ed il coinvolgimento di YaiW 
nell’internalizzazione di Bac7 mediata da SbmA può essere ipotizzato sulla base dell’aumentata 
resistenza al peptide mostrata dal ceppo con una delezione completa del gene yaiW.  
Dal vaglio in vivo dell’intero proteoma di E. coli versus SbmA mediante il sistema BACTH non è 
stato identificato alcun dominio di legame dell’ATP, rafforzando quindi l’ipotesi che il sistema di 
trasporto rappresentato da SbmA non richieda l’idrolisi dell’ATP come fonte di energia. Questo 
studio ha permesso di identificare 9 possibili interattori di SbmA, tra i quali la proteina della 
membrana interna FieF, coinvolta nell’efflusso di ioni Zn(II) dalla cellula batterica.  
E’ stato mostrato come FieF sia coinvolta nell’internalizzazione di Bac7 mediata da SbmA e come 
l’espressione di sbmA sia modulata dagli ioni Zn(II) in maniera complessa, suggerendo un possibile 
ruolo per questa proteina nella risposta allo stress da parte del batterio.  
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Questi risultati suggeriscono come SbmA sia un insolito trasportatore di peptidi derivato dalla 
famiglia dei trasportatori ABC, che ha successivamente perso e/o cambiato nel corso 
dell’evoluzione alcune caratteristiche, come ad esempio la necessità di una proteina di legame del 
substrato o la fonte di energia richiesta per il trasporto dei substrati.  
Inoltre, l’interazione osservata tra le due proteine SbmA e FieF potrebbe suggerire un possibile 
ruolo della prima nel processo di detossificazione dello zinco, attività che potrebbe essere modulata 
dal legame di un substrato di natura peptidica a SbmA.  
Infine, la regolazione dell’espressione di sbmA mediata dagli ioni Zn(II) potrebbe avere un ruolo 
fisiologico nell’ospite in quanto promuove una maggiore suscettibilità dei batteri ai peptidi 
antimicrobici ed è in grado di attivare effettori cellulari come i neutrofili.  
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1. INTRODUCTION 
1.1. The innate (or natural) immune system 
 
Some basic defence mechanisms evolved in ancient eukaryotes remain in their modern descendants, 
such as plant and insects, including phagocytosis, antimicrobial peptides (e.g. defensins) and the 
complement system. In the vertebrates the immune system shows a more complex organization, 
based on the two different components of the innate (or natural) immunity and the adaptive (or 
acquired) immunity.  
The first line of defence against infections is represented by mechanical, chemical and biological 
barriers. In the vertebrates the epithelia, such as the skin and mucosae, represent a physical barrier 
to reduce the risk of infection. However, as organisms can not be completely sealed against their 
environments, there are other systems acting to protect the surfaces that are likely to enter in contact 
with pathogens, such as lungs, the intestine and the genitourinary tract. In the lungs coughing and 
sneezing mechanically eject pathogens and other irritants from the respiratory tract, or the mucus 
secreted by the respiratory and gastrointestinal tract serves to trap and entangle microorganisms. 
Chemical barriers also protect against infections. The skin and the epithelia of the respiratory tract, 
e.g., secrete antimicrobial peptides such as the β-defensins (Agerberth and Gudmundsson, 2006), 
and enzymes such as lysozyme and phospholipase A2 in saliva, tears and breast milk also exert an 
antimicrobial activity (Moreau et al., 2001; Hankiewicz and Swierczek, 1974). With respect to the 
biological barriers, within the genitourinary and gastrointestinal tracts, the normal commensal flora 
represents a natural way of limiting the propagation of exogenous pathogens by competing for food 
and space and, in some cases, by changing the environmental conditions such as pH and available 
iron (Gorbach, 1990).  
If a pathogen breaches all these first-line barriers, then other innate immune mechanisms provide an 
immediate but non-specific response. The innate response is usually triggered when 
microorganisms are identified by Pattern Recognition Receptors (PRRs) expressed on the surface of 
immune cells, which are able to recognize components that are conserved among broad groups of 
microbes (Medzhitov, 2007), or when damaged, injured or stressed cells send out alarm signals 
(Matzinger, 2002). This type of response is the dominant system of host defense in many organisms 
and is mediated by a humoral and a cellular component. The humoral component is represented by 
the cytokines and the complement factors. Cytokines are small cell-signalling protein molecules 
secreted by endo- or epithelial cells and macrophages with the aim of modulating the immune 
response. In particular, they are generally released by damaged or injured cells to attract white 
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blood cells (leukocytes), e.g. during inflammation, and may be classified into interleukines, that are 
responsible for communication between leukocytes, chemokines, that promote chemotaxis, and 
interferons that exert anti-viral effects. The complement factors are the major humoral component 
of the innate immune system and help the ability of antibodies and phagocytic cells to eliminate 
pathogens from an organism. Since there is a complex network integrating the innate and adaptive 
immunity, the complement system is part of the former but can be recruited also by the latter. The 
functions of the complement factors include the opsonization of antigens enhancing the 
phagocytosis process, the chemotaxis to attract macrophages and neutrophils in situ, or direct action 
in disrupting the membranes of the pathogens (Rus et al., 2005). The classical complement pathway 
typically requires antigen:antibody complexes for activation and is part of the adaptive immune 
system, whereas the alternative and mannose-binding lectin pathways can be activated without the 
presence of antibodies and is part of the innate immune system. In all these pathways a cascade of 
proteolytic cleavages amplifies the initial signal and mediates the activation of the immune 
response.  
The cellular component of the innate immune system is represented by the so-called innate 
leukocytes that include the phagocytes (macrophages, neutrophils and dendritic cells), mast cells, 
eosinophils, basophils and natural killer cells. These cells are able to attack and engulf 
microorganism but are also important mediators in the activation of the adaptive immune response.  
Phagocytosis is a process mediated by the phagocytes that can be called to a specific district of the 
organism by cytokines (Alberts et al., 2002). Once a pathogen has been engulfed by a phagocyte, it 
becomes trapped in an intracellular vescicle called a phagosome, which subsequently fuses with 
another vesicle called a lysosome to form a phagolysosome. The pathogen is killed by the activity 
of digestive enzymes or following a respiratory burst that releases free radicals into the 
phagolysosome. This process probably represents the oldest form of host defense, as phagocytes 
have been identified in both vertebrate and invertebrate animals (Salzet et al., 2006). Neutrophils 
are the most abundant type of phagocyte, normally representing the 50% to 60% of the total 
circulating leukocytes, and are the first leukocytes to migrate towards the site of inflammation, 
particularly when it is the result of bacterial infection, in a process called chemotaxis. Macrophages 
are versatile cells that reside within tissues and produce a wide array of chemicals including 
enzymes, complement proteins, and regulatory factors, but most importantly they can act as 
professional Antigen-Presenting Cells (APCs) to activate the adaptive immune response. Other 
professional APCs are represented by the dendritic cells (Guermonprez et al., 2002), usually located 
in tissues that are in contact with the external environment such as skin, mucosae of the nose, lungs, 
stomach and intestine. Mast cells reside in the connective tissue and the mucosae and play a role in 
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regulating the inflammatory response, both physiological and related to allergy (Krishnaswamy et 
al., 2006). Basophils and eosinophils are related to neutrophils and secrete chemical mediators 
involved in defending against parasites and allergic reactions such as asthma (Kariyawasam and 
Robinson, 2006). Natural killer cells (NK) are responsible for the defense against tumorigenic 
processes and viral infection (Middleton et al., 2002), releasing small cytoplasmic granules of 
proteins called perforin and granzyme that cause the target cell to die by apoptosis (programmed 
cell death).  
1.2. Antimicrobial peptides 
 
Antimicrobial peptides (AMPs) are an important element of the humoral component of the innate 
immunity and are molecules widely distributed both in the animal and the plant kingdom. Up to 
now more than 800 sequences of AMPs have been identified in insects, shellfish, crustaceans, 
amphibian, fish, birds and mammals, including humans (Hancock and Scott, 2000; Brogden et al., 
2003; Wang et al., 2009; Thomas et al., 2012). In the plants AMPs may be found mainly in seeds 
and leaves, while in the invertebrates they have been found in the hemolymph and in the 
cytoplasmic granules of the hemocytes. In vertebrates AMPs are secreted by the gland and 
epithelial cells of tissues that are likely to come in contact with the external environment, such as 
skin, respiratory tract, intestine and genitourinary apparatus (Ganz and Lehrer, 1999), and are 
produced and stored in large amounts also into the cytoplasmic granules of the cells of the immune 
system, such as the neutrophils.  
Although called “antimicrobial peptides”, their antimicrobial action is not the only one. Indeed 
these molecules play an important role also in modulating the immune response and mediating the 
inflammatory process (Bals, 2000). Since the AMPs are part of the immune system, they may be 
able to discriminate between self and non-self elements, in order to address their activity mainly 
against microbial cells, and this aim is achieved on the basis of the different composition of the 
prokaryotic and eukaryotic cellular membranes. In the bacteria both the outer membrane of Gram 
negative ones both the outer leaflet of the cellular membrane present a high percentage of negative 
charges, while in the eukaryotic cellular membrane all these charges are mainly exposed to the 
cytoplasmic side. Moreover the eukaryotic cellular membranes are enriched in cholesterol, which is 
important to stabilize the membrane but is absent in the prokaryotic membranes (Epand et al., 1999; 
Lohner, 2009). The potential toxicity of AMPs is also controlled by their compartimentalization in 
the cytoplasmic granules of the immune system cells and by the requirement of a proteolytic 
cleavage to be released into an active form.  
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1.2.1. Classification of AMPs 
 
The most common classification for the AMPs is based on mixed criteria such as charge, structural 
conformation, prevalence of specific amino acids and presence and number of disulphide bonds 
(Brogden, 2005). Following these criteria, antimicrobial peptides may be classified into (Figure 
1.1): i) linear, cationic, α-helical peptides present in invertebrates (Hancock et al., 2006), like 
cecropins in Hyalophoracecropia moth (Steiner et al., 1981) and melittin in honeybee (Dufourcq 
and Faucon, 1977), and in vertebrates, like pleurocidin in the winter flounder (Cole et al., 1997), 
magainins in Xenopus frogs (Zasloff, 1987), cathelicidin-BF in Bungarus snake (Wang et al., 
2008), myeloid antimicrobial peptides in cattle [BMAPs, (Skerlavaj et al., 1996)], pigs [PMAPs, 
(Storici et al., 1994)] and sheep [SMAP-29, (Skerlavaj et al., 1999)], and finally CAP18 in various 
mammals, such as rabbit (Larrick et al., 1993) and LL-37 in humans (Agerberth et al., 1995); ii) 
cationic peptides enriched for specific amino acids, such as the proline-rich apidaecin and abaecin 
in honeybee (Casteels et al., 1989; Casteels et al., 1990), drosocin in Drosophila (Bulet et al., 
1993), bactenecins from cattle (Bac7), sheep and goats (Gennaro et al., 1989; Shamova et al., 1999) 
and PR-39 in pigs (Agerberth et al., 1991), the proline/phenylalanine-rich porcine prophenin 
(Harwig et al., 1995), the histidine-rich human histatins (Kavanagh and Dowd, 2004; Oppenheim et 
al., 1986), the tryptophan-rich indolicidin from cattle (Selsted et al., 1992) and serine/glycine-rich 
cathelicidins in salmonids (Scocchi et al., 2009); iii) anionic and cationic peptides containing 
cysteine and forming disulphide bonds, such as brevinins with one S-S bond (Morikawa et al., 
1992), porcine protegrins (Kokryakov et al., 1993) and tachyplesin in horseshoe crab (Nakamura et 
al., 1988) with two bonds, or three bonds, as in the family of defensins present in vertebrate species 
(Lehrer and Ganz, 2002) and insects (Lambert et al., 1989). More than three bonds are present in 
antifungal plant defensins (Thomma et al., 2002) and in a structurally similar peptide named 
drosomycin from Drosophila (Fehlbaum et al., 1994); iv) anionic peptides, such as maximin H5 
(Lai et al., 2002), several glutammate/aspartate-rich anionic peptides in sheep (Brogden et al., 
1997) and human dermcidin (Schittek et al., 2001), which seem to exert their microbicidal activity 
as secondary to different principal activities, and their detailed characteristics are still to be 
elucidated (Harris et al., 2009).  
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Figure 1.1. Classification and structures of the AMPs. 
 
Finally, a separate group consists of antimicrobial peptides derived from fragmented proteins or of 
antimicrobial domains of larger proteins. The examples include lactoferricin, a fragment of 
lactoferrin cleaved by pepsin (Gifford et al., 2005), casein-derived casocidin from bovine milk 
(Zucht et al., 1995), or proteolytic fragments of ovalbumin (Pellegrini et al., 2004).  
1.2.2. The cathelicidin family and the proline-rich AMPs 
 
Two main families of AMPs were identified in mammals, the defensins and the cathelicidins, while 
a third family, the histatins, was found only in primates. Defensins are cationic, non-glycosilated 
peptides with a molecular mass ranging from 3.5 to 4.5 kDa containing six cysteine residues 
required for the formation of three peculiar intramolecular disulphide bonds (Lehrer et al., 1991; 
Fellermann and Stange, 2001). On the basis of the position of the cysteine residues and the resulting 
structure, the defensins are classified into α- and β-defensins, among those there are the human 
defensins (Selsted et al., 1985), and θ-defensins from the rhesus monkey (Tang et al., 1999).  
On the other hand, cathelicidins are represented by several AMPs found in many different 
vertebrates, including all mammals species (Zanetti et al., 1995). These AMPs have a C-terminal 
domain, which is highly variable and corresponds to the active part of the molecule (with a length 
ranging from 20 to 100 amino acids), and a N-terminal domain with a length of approximately 100 
residues, which corresponds to the proregion eliminated after proteolytic cleavage and shows a level 
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of conservation among different species equal to or even higher than 75% (Scocchi et al., 1997; 
Gennaro and Zanetti, 2000).  
The most ancient example of cathelicidin-like peptides was isolated from the hagfish (Myxine 
glutinosa) (Uzzel et al., 2003): the proregion of this peptide shows a limited sequence similarity 
with the proregion of mammal cathelicidins (Figure 1.2), but the presence of typical motifs, such as 
the sequence F-X(3)-E-T-X-C-X(10)-C, reveals that also this peptide is part of the cathelicidin 
family (Tomasinsig and Zanetti, 2005). AMPs belonging to the cathelicidins family have been 
identified also in birds and in fishes (Scocchi et al., 2009; Tomasinsig and Zanetti, 2005).  
 
 
 
Figure 1.2. Sequence alignment of non-mammals cathelicidins with the bovine bactenecin Bac5. Amino acid 
residues conserved among at least three species are in bold letters. The capital letters correspond to the sequence of the 
proregion, while the small letters correspond to the sequence of the mature peptide. The frame indicates the conserved 
region among the different species (Tomasinsig and Zanetti, 2005).  
 
It was proposed that the highly conserved sequence enriched in acid amino acids may play an 
important role in maintaining the peptide in its inactive form within the cell through the interaction 
between these acid residues and the basic ones of the C-terminal region (Scocchi et al., 1992; 
Zanetti et al., 1995).  
The cathelicidins are synthesized during the assembly of the cytoplasmic granules in the neutrophils 
as pre-propeptides with an N-terminus signal sequence and then they are stored in the granules as 
inactive precursors. The mature peptides, which show antimicrobial activity, are released in the 
extracellular medium or in the phagosome only after neutrophils stimulation and consequent 
proteolytic cleavage by the elastase or protease 3 (Zanetti et al., 1991; Scocchi et al., 1992; 
Panyutich et al., 1997).  
The genes encoding the cathelicidins in mammals have a length of approximately 2 kb and share a 
common organization, with four exons and three introns, encoding the signal sequence, the N-
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terminal cathelin-like domain and the sequence corresponding to the mature peptide (Figure 1.3A) 
(Tomasinsig and Zanetti, 2005; Hancock and Diamond, 2000).  
Among the cathelicidins, an important subgroup is represented by the proline-rich peptides, found 
both in mammals and invertebrates species, even if the latter are not evolutionary linked. To this 
class of peptides belong linear peptides characterized by a high content of proline residues (often 
around 50% of the whole sequence) and a high number of positive charges carried by arginine or, 
less commonly, lysine residues (Gennaro et al., 2002). The first members of this class of peptides to 
be identified were the apidaecin in the honeybee (Casteels et al., 1989) and the bovine bactenecins 
Bac5 and Bac7 (Gennaro et al., 1989). Another member of this family was identified from swine 
intestine and named PR-39 on the basis of the high content of proline and arginine residues and the 
length of the sequence (Agerberth et al., 1991). Despite all belonging to the cathelicidin family of 
precursors and having the characteristic high content of Pro and Arg residues, mammalian proline-
rich AMPs have quite different lengths and primary sequences (Figure 1.3B). 
 
 
 
Figure 1.3. Structure of the cathelicidins and amino acid sequences of the mature peptides in vertebrate animals.  
a
 Tandem repeats present in some sequences are underlined with alternating single and dashed underlines. b Sequence is 
from a putative pseudogene. c Net charge, His residues are considered neutral. d Putative peptide size. Charge and 
percentage of proline residues are based on this sequence. e œ pyroglutamic acid. (Modified from Hancock and 
Diamond, 2000; Scocchi et al., 2011).  
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As shown in Figure 1.3B, despite their similar amino acid composition, these peptides show 
differences in the length and sequence of the repeated proline-rich motifs. Bac7, e. g., is a peptide 
with 60 amino acid residues in the mature form, which shows a proline every two residues starting 
from the eleventh, and three tandem repetitions of the same tetradecamer with the triplet Pro-Arg-
Pro starting from the fifteenth residue (Frank et al., 1990). On the other hand, Bac5 is a 43 residues 
peptide with a sequence characterized by the Xaa1-Pro-Pro-Xaa2
 
motif, repeated nine times, where 
Xaa1 usually corresponds to an arginine residue, while Xaa2 to a hydrophobic residue (Ile, Phe o Leu) 
(Frank et al., 1990).  
Finally PR-39 shows a high similarity with Bac7 in the first 15 amino acids but then it shows 7 
Xaa1-Pro-Pro-Xaa2 repeated motifs, completely different from those of Bac5 because Xaa1 
corresponds to a hydrophobic residue while Xaa2 to an arginine (Agerberth et al., 1991).  
Circular dichroism and NMR studies on PR-39 (Cabiaux et al., 1994) and Bac5 with its fragments 
(Raj and Edgerton, 1995), both in aqueous solution and in presence of lipid vesicles, suggested that 
the active conformation for these peptides may be of the type of poly-L-proline II. This hypothesis, 
however, is still under discussion since chemical-physical calculations indicate that Bac5 and Bac7 
may share a new and singular secondary structure which is called γ-helix (Tani et al., 1995).  
An important common feature of all these peptides is their antimicrobial activity directed mainly to 
Gram negative bacteria (and in particular against the Enterobacteriaceae), while only a few Gram 
positive species are susceptible (Bacillus megaterium, Bacillus subtilis and Listeria monocytogenes) 
(Gennaro et al., 2002; Otvos, 2002). Moreover in vivo studies demonstrated that the proline rich 
peptides show very low toxicity towards the eukaryotic cells (Otvos et al., 2000; Tomasinsig et al., 
2006; Benincasa et al., 2010) and this feature makes them particularly suitable as new therapeutics.  
1.2.3. Modes of action 
 
Peptide-mediated cell killing can be rapid: some linear α-helical peptides kill bacteria so quickly 
that it is technically challenging to characterize the steps preceding cell death (Boman et al., 1995). 
Other peptides, such as PR-39 (Boman et al., 1993), magainin 2 (Zasloff, 1987) and SMAP-29 
(Kalfa et al., 2001), kill bacteria in 15-90 minutes. Regardless of the time required, or the specific 
antimicrobial mechanism, specific steps must occur to induce bacterial killing.  
First, antimicrobial peptides must be attracted to bacterial surfaces and this usually occurs through 
electrostatic interactions between cationic peptides and structures on the bacterial surface, such as 
the anionic phospholipids and the phosphate groups on lipopolysaccharide (LPS) of Gram negative 
bacteria or the teichoic acids on the surface of Gram positive bacteria. Once close to the microbial 
surface, many AMPs act via a lytic mechanism permeabilizing the bacterial membrane, while 
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others, such as the proline-rich peptides, are internalized into the bacterial cell and exert their 
activity through the inhibition of intracellular processes.  
1.2.3.1. Membrane permeabilization 
 
The first of the three currently supported membrane permeabilization models is the “barrel-stave” 
model (Figure 1.4). It proposes a pore formation by a bundle of peptide molecules spanning the 
lipid bilayer and lining the hydrophobic core like barrel-staves. Even though it was historically the 
first model proposed, it is currently known to be true only in the case of alamethicin (Yang et al., 
2001). 
 
 
 
Figure 1.4. Modes of action of the AMPs. Hydrophilic regions of the peptide are shown coloured red, hydrophobic 
regions are shown coloured blue (modified from Brogden et al., 2005). 
 
The “carpet” model was first described for dermaseptins (Pouny et al., 1992) and then for several 
other AMP families, e.g. cecropins. Membrane permeabilization in this model occurs in a detergent-
like manner, leading to the formation of micelles. A peptide molecule is orientated parallelly to the 
membrane, does not get completely inserted into the hydrophobic core and does not contact the 
hydrophilic parts of other peptide molecules. After an electrostatically driven interaction with the 
polar phospholipid head groups, the peptide places its hydrophobic face towards the fatty acid 
chains and the hydrophilic face towards the surface. Once the threshold concentration is reached, a 
disintegration occurs by disrupting the local bilayer curvature (Shai, 2002). 
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In the third model called the “toroidal pore” model, peptide molecules insert into the membrane and 
induce the lipid monolayers to bend continuously through the pore so that the water core is lined by 
both the inserted peptides and the lipid head groups (Matsuzaki et al., 1996). In forming a toroidal 
pore, the polar faces of the peptides associate with the polar head groups of the lipids (Yamaguchi 
et al., 2002). The lipids in these openings then tilt from the lamellar normal and connect the two 
leaflets of the membrane, forming a continuous bend from the top to the bottom. The toroidal model 
differs from the barrel-stave model as the peptides are always associated with the lipid head groups 
even when they are perpendicularly inserted in the lipid bilayer (Yang et al., 2001).  
1.2.3.2. Models of intracellular killing 
 
Some AMPs do not show highly membranolytic properties and therefore are internalized into the 
bacterial cell via a different mechanism and exert their antimicrobial action on intracellular targets. 
The honeybee AMP hymenoptaecin, e. g., crosses the membrane causing a transient 
permeabilization effect which does not damage permanently the bacterial membrane (Casteels et 
al., 1993). Proline-rich AMPs, such as apidaecin (Castle et al., 1999) and Bac7, are expected to 
cross the bacterial membrane via a transporter-mediated process. In particular, for the latter a point 
mutation in the gene encoding SbmA, an integral transmembrane protein, leads to a significant 
decrease in the susceptibility to Bac7 and other proline-rich peptides by E. coli cells (Mattiuzzo et 
al., 2007). The complete deletion of the gene makes bacterial cells even more resistant to the 
peptide by reducing the uptake of Bac7 up to 70%.  
Another example of a transporter-mediated internalization of AMPs is represented by histatin-5 
(Hst5), one of the histidine-rich AMPs endowed with antifungal activity. This peptide binds a 
protein located in the fungal cell envelope, Ssa1/2, that functions as a peptide receptor (Kavanagh 
and Dowd, 2004; Li et al., 2003) and it is then translocated into the cytosol by a polyamine 
permease. This class of transmembrane carriers is responsible for spermidine, spermine and 
putrescine transport (Uemura et al., 2007) and also for the uptake of the anticancer drug bleomycin 
that bears a spermidine substituent at its terminal amine (Aouida et al., 2004). Polyamine permeases 
are energized by the proton motive force and indeed the cytosolic translocation of Hst5 was found 
to be strongly energy-dependent, thus suggesting the involvement of these class of transporters 
(Woong et al., 2010; Kumar et al., 2011).  
Once within the bacterial cell, two major target mechanisms have been found to be interfered by the 
cell penetrating AMPs: i) inhibition of cell division and induction of filamentation (abnormal cell 
elongation), that are the effects of the inhibition at various stages of DNA, RNA and protein 
synthesis, have been observed in several Gram negative strains after the treatment with PR-39 
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(Boman et al., 1993) and indolicidin (Subbalakshmi and Sitaram, 1998); ii) disruption of the 
respiratory mechanisms leading to the generation of reactive oxygen species is the killing strategy 
employed by histatins against fungi (Kavanagh and Dowd, 2004) and by microcin J25, an 
antibacterial peptide synthesized by E. coli, which also presents RNA polymerase inhibition in 
Gram negative bacteria (Bellomio et al., 2007). With respect to the intracellular targets of the 
bactenecin Bac7, its mechanism of action after the SbmA-mediated uptake is still under 
investigation but it is supposed to involve inhibition of general biological processes such as DNA, 
RNA  and protein synthesis.  
1.3. The E. coli inner membrane protein SbmA 
 
sbmA was first identified as a gene that mediates the susceptibility of bacteria to the microcins B17 
and MccJ25 (Lavina et al., 1986; Salomon and Farias, 1995), two antibacterial peptides of bacterial 
origin, and was subsequently also found to confer susceptibility to the glycopeptide antibiotic 
bleomycin (Yorgey et al., 1994). It was found that strains lacking this gene showed a complete 
resistance to the microcins and an increased resistance to bleomycin (Yorgey et al., 1994; Salomon 
and Farias, 1995). More recently a role for this gene in the susceptibility of bacteria to the 
bactenecin Bac7 was showed (Mattiuzzo et al., 2007).  
From the analysis of its 406 amino acids sequence, it was deduced that SbmA is an inner membrane 
protein with seven transmembrane spanning domains (Glazebrook et al., 1993; LeVier and Walker, 
2001), although the exact number of transmembrane helices with respect to the C-terminus of the 
protein remains controversial. This part of the protein is highly hydrophobic and therefore may 
correspond to the eighth transmembrane domain. Regarding the localization of the C-terminus of 
the protein, Daley et al. suggest a cytoplasmic localization for the C-terminus of SbmA, on the basis 
of a global topology analysis conducted on the Escherichia coli inner membrane proteome (Daley et 
al., 2005).  
SbmA is predicted to be the transmembrane domain of an ABC transporter and since it was showed 
to play a role in the uptake of structurally different, non-membrane disrupting peptides (Lavina et 
al., 1986; Salomon and Farias, 1995; Yorgey et al., 1994; Mattiuzzo et al., 2007), it is likely a 
peptide transporter (de Cristobal et al., 2006). Intriguingly, this protein shows, within the most 
conserved region of the whole protein, a short hydrophilic sequence that is highly conserved in 
ABC uptake system, the so-called EAA motif.  
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1.3.1. ABC (ATP-binding cassette) transport systems 
 
The ABC superfamily is represented by several different transport systems, found both in animals 
or plants (Shitan et al., 2003; Terasaka et al., 2005) and in prokaryotes or Archaea, that mediate the 
transport of a big variety of substrates such as ions, sugars, amino acids, vitamins, lipids, 
antibiotics, drugs and oligosaccarides or oligopeptides (Higgins, 1992). Although these transport 
systems may be very different with respect to the transport direction across the membrane and the 
types of substrates, they share a common general organization with two hydrophobic 
transmembrane domains (TMDs) and two cytoplasmic nucleotide-binding domains (NBDs), also 
called ABC (ATP-binding cassette) domains. These four domains correspond to the essential core 
of the transport system, which may have some additional domains such as those associated on the 
extracellular or intracellular side of the cellular membrane (e. g. the periplasmic binding protein, 
PBP). In E. coli, the complete sequence of the genome (Blattner et al., 1997) identified 79 genes 
encoding ABC proteins and corresponding to 2.1% of the whole genome (Linton and Higgins, 
1998). These 79 proteins, which possess an ABC domain to hydrolyse ATP, take part to 69 
independent functional systems, among those 57 are transporters (44 uptake systems and 13 
putative efflux pumps) and among the remaining 12 systems, that don’t seem to play a role in 
transport, the function of only one of them (UvrA) is known.  
In prokaryotes the first component of an ABC uptake system to be identified was the periplasmic 
binding protein (PBP), a soluble protein located in the periplasmic space of Gram negative bacteria 
(Neu et al., 1965) or exposed on the cellular surface in Gram positive bacteria and Archaea, hooked 
to the cytoplasmic membrane via a lipid anchor or a transmembrane peptide, or fused to the TMDs 
(Biemans-Oldehinkel et al., 2006). The different domains may correspond to different chains or 
may be fused in a unique chain, thus reducing the total number of subunits (Figure 1.5).   
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Figure 1.5. Domain architecture of ABC transporters. Schematically indicated are: PBPs (pac-man shaped), TMDs 
(rectangles), and NBDs (ovals). A) Gram-negative bacteria (all the examples are from Escherichia coli): Nik, nickel 
transporter; Mal, maltose/maltodextrin transporter; Btu, vitamin B12 transporter; Fhu, siderophore/haem/vitamin B12 
transporter. B) Gram-positive bacteria and Archaea: Opp, oligopeptide transporter from Lactococcus lactis; Glc, 
glucose transporter from Sulfolobus solfataricus; OpuA, glycine betaine transporter from Lactococcus lactis. C) Msb, 
lipid flippase from Escherichia coli; Cyd, cysteine exporter from Escherichia coli (modified from Biemans-Oldehinkel 
et al., 2006).  
 
Although the common four-domain structure of the transporter (two TMDs plus two NBDs) is 
conserved, ABC efflux pumps do not require a PBP for function. Even more frequently than in 
ABC uptake systems, the four core-domains of the translocator are fused, as for the “half-size 
transporter” in which a single TMD is fused to the N- or C-terminus of a NBD. The functional 
complex is either a homo- or heterodimer of two half-transporters.  
The TMDs are two highly hydrophobic proteins that are bundles of α-helices conforming to the 
paradigmatic “two-times-six” α-helices structure, yielding a total of 12 transmembrane segments 
per functional unit. However, the number of transmembrane helices may vary from 5 to 11 for each 
individual TMD. Although the TMDs (as well as the PBPs) are less conserved during evolution 
with respect to the NBDs, reflecting the large diversity of substrates transported, the TMDs of ABC 
uptake systems contain the so-called EAA motif (L-loop), which usually is found in the cytoplasmic 
loop between helices 5 and 6 (Saurin and Dassa, 1994) and is absent in ABC exporters.  
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The engines of ABC transporters are the NBDs as these power substrate translocation by ATP-
binding and hydrolysis. In the NBD monomer, the ATP-binding site is formed by two conserved 
sequences, the Walker A (P-loop) and Walker B motifs, present in many ATP-binding proteins and 
not restricted to ABC proteins (Walker et al., 1982). These motifs bind the phosphates of ATP and 
ADP, and coordinate a Mg2+-ion via H2O in the nucleotide-binding site, respectively. In the NBD 
dimer, the signature sequence LSGGQ, (the motif that distinguishes ABC proteins from other 
nucleotide-binding proteins) of one NBD binds to the γ-phosphate of ATP bound to the other NBD, 
thereby completing the nucleotide-binding sites (Davidson and Chen, 2004). Thus, two ATPs are 
sandwiched in head-to-tail orientation between two NBDs in the catalytically active dimer.  
1.3.2. Distribution of SbmA and its homologs among the bacterial species  
 
Orthologues of the sbmA gene have been identified in numerous Gram negative bacterial species 
such as Salmonella thyphimurium, Shigella flexneri and Klebsiella pneumoniae, but not in Gram 
positives. Other orthologues known as bacA have been identified in Sinorhizobium meliloti, 
Brucella abortus and Mycobacterium tuberculosis. It is interesting to note that sbmA/bacA has no 
close homologues in Pseudomonas aeruginosa, and that this Gram negative organism is in general 
much less susceptible to the bactenecin Bac7 than the Enterobacteriaceae (Benincasa et al., 2004).  
SbmA is a protein with unknown function in E. coli, but some clues may be inferred from its 
homology with the BacA protein in Sinorhizobium meliloti, a Gram negative alpha-proteobacterial 
symbiont of legumes. Sequence alignment of SbmA of E. coli and S. meliloti reveals a 62% identity 
(74% similarity) between the two proteins (Glazebrook et al., 1993) (Figure 1.6A). Moreover the 
Kyte-Doolittle hydrophobicity profiles are virtually superimposable (Figure 1.6B), suggesting that 
the two proteins adopt similar conformations (Glazebrook et al., 1993). The putative cytoplasmic 
stretches are more conserved (78% identity, compared with 62% identity overall) than are the other 
regions of SbmA of E. coli and S. meliloti, and this may be an indication that the cytoplasmic loops 
perform a function that is conserved between the two bacterial species.  
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Figure 1.6. Sequence alignment and hydropahty plots of SbmA of E. coli and S. meliloti. A) Alignment of E. coli 
and S. meliloti SbmA/BacA (global alignment using the Needleman-Wunsch algorithm). Lines indicate identical 
residues, double dots indicate conservative substitutions and single dots indicate less conservative substitutions. B) 
Kyte-Doolittle hydropathy plots of E. coli and S. meliloti SbmA/BacA (Kyte and Doolittle, 1982). Positive values 
indicate increasing hydrophobicity. A window of 11 amino acids was used for the scan (modified from Glazebrook et 
al., 1993).  
 
SbmA/BacA of Sinorhizobium meliloti, was found to be essential for the normal development of 
alfalfa nodules and the differentiation of the bacteria into bacteroids, while its orthologs in Brucella 
abortus, an alpha-proteobacterial pathogen that induces spontaneous abortion in chronically 
infected cows, and in Mycobacterium tuberculosis were shown to be important for the 
establishment of chronic infection in mice (LeVier et al., 2000; Domenech et al., 2009). Among 
SbmA/BacA homologs, a distinct subgroup of proteins named BacA-related proteins have been 
found in different sequenced microbial genomes. These proteins show a lower similarity (38 to 
59%) than that of the S. meliloti SbmA/BacA proteins and are approximately 200 amino acids 
longer. At the C termini, they present Walker A and B motifs, as well as an ABC signature 
sequence (LeVier and Walker, 2001). They are characterized by the presence of two hydrophobic 
transmembrane domains (TMDs) and two cytoplasmic nucleotide-binding domains and can act 
either as exporters or as importers. In the latter case, there is often an extracytoplasmic region 
involved, named the substrate-binding domain, that in the case of Gram positive bacteria is 
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anchored to the cell membrane by a lipid tail at the amino end (Braibant et al., 2000; Dassa and 
Bouige, 2001; Higgins, 2001; Lage, 2003; Linton and Higgins, 1998; Young and Holland, 1999). 
BacA-related proteins are present both in S. meliloti (ExsE) and in E. coli (YddA). The exsE gene is 
part of a cluster of genes involved in the succinoglycan biosynthesis, although ExsE does not play a 
direct role in the synthesis of this molecule and is not essential for successful symbiosis with alfalfa 
(Long et al., 1988). The YddA protein of E. coli is predicted to be an inner membrane protein of 
unknown function that may facilitate growth under optimal conditions (rich medium at 37°C) 
(Serina et al., 2004).  
1.3.3. SbmA/BacA functions 
 
So far the biological function of these BacA-related proteins is still unknown as well as of their 
relationship with the proteins of the SbmA/BacA group.  
With respect to the E. coli SbmA, Mattiuzzo et al. showed that this protein is essential to mediate 
the internalization of Bac7 (Mattiuzzo et al., 2007). Measuring the level of internalized fluorescent 
peptide by flow cytometry after treatment with an impermeant quencher, they were able to 
discriminate between the fluorescence of the peptide bound to the surfaces of the bacterial cells and 
that given by inaccessible internalized peptide. In this manner they demonstrated that the 
concentration of the peptide inside the SbmA-deficient strain was significantly lower. Moreover, a 
normal peptide level inside the cells could be restored by introducing a plasmid-encoded wild-type 
sbmA gene (Figure 1.7A). These results are in agreement with those obtained by confocal analysis 
(Figure 1.7B) and confirm that a functional SbmA is required for peptide internalization. These 
results have been the first evidence that the uptake of antimicrobial peptides of animal origin, such 
as Bac7, were shown to be dependent on a bacterial protein and have suggested a function for 
SbmA as a peptide transporter in general.  
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Figure 1.7. A functional SbmA is required for the internalization of the proline-rich peptide Bac7. A) 
Measurement of the amount of internalized Bac7(1-35)-BY 0.25 µM as Medium Fluorescence Intensity (M.F.I.) in the 
wild-type, SbmA-deleted strain and after complementation via the plasmid pMAU1. * p < 0.05 for BW25113 ∆sbmA 
strain versus BW25113 or BW25113 ∆sbmA [pMAU1(sbmA)] strain. B) Confocal microscopy images of E. coli 
BW25113 and ∆sbmA cells exposed to BODIPY-labeled Bac7 0.25 µM.  
 
Despite the different origin, the S. meliloti BacA shows functional interchangeability with the 
SbmA protein of E. coli (Ichige and Walker, 1997). The resistance phenotype to microcins B17 and 
J25 of an E. coli sbmA-deficient strain was analyzed and the ability of a plasmid-encoded bacA 
wild-type gene of S. meliloti to restore a normal level of sensitivity towards these two compounds 
was demonstrated (Ichige and Walker, 1997). Moreover, the sbmA gene expressed under the control 
of the bacA promoter has the capability to complement the defects of S. meliloti bacA mutants with 
respect to the formation of the nodules and the development of bacteroids (Ichige and Walker, 
1997). Interestingly, the observation that sbmA has to be placed under the control of the endogenous 
bacA promoter in order to complement the defects of bacA mutants suggests that the proper 
regulation of the expression of these proteins is important for them to be effective in bacteroid 
development of S. meliloti. Furthermore, more recently, it was demonstrated also the involvement 
of SbmA/BacA of S. meliloti in the uptake of the proline-rich peptide Bac7. Indeed it was shown 
that both the S. meliloti and E. coli SbmA/BacA were able to sensitize S. meliloti towards a 
truncated derivative of Bac7 and that this susceptibility of the bacteria to the peptide was mediated 
by the internalization of Bac7 via the SbmA/BacA transporter (Marlow et al., 2009).  
Finally, a similar experiment of heterologous expression conducted in E. coli demonstrated that also 
the SbmA/BacA protein of Mycobacterium tuberculosis is able to restore the normal sensitivity to 
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the proline-rich peptide Bac7 of a SbmA-deficient strain (Domenech et al., 2009), thus underlining 
once again the ability of functionally complement each other of these two protein homologs.  
Although a general in vivo function of SbmA/BacA remains still unknown, an interesting 
observation comes from the production of unusual very-long-chain fatty acid (VLCFA) modified 
lipids in S. meliloti, B. abortus and M. tuberculosis carrying a wild-type SbmA/BacA protein 
(Domenech et al., 2009; Ferguson et al., 2004; Haag et al., 2011a). The fact that SbmA/BacA 
affects VLCFA modification of a component of the bacterial envelope, the lipopolysaccharide 
(LPS), both in S. meliloti and B. abortus, is consistent with the hypothesis that a SbmA/BacA-
mediated change in the VLCFA modification of the LPS is critically important for the chronic 
intracellular infection that underlies S. meliloti symbiosis and B. abortus chronic infection 
(Ferguson et al., 2004; Ferguson et al., 2002; Haag et al., 2011a). However VLCFA are not present 
in E. coli, suggesting that other cellular components are necessarily involved in the activity of this 
protein.  
Recently a new model has been proposed to explain the role of SbmA/BacA in the development of  
the symbiosis between S. meliloti and Medicago truncatula roots (Haag et al., 2011b). The bacteria 
induce the formation of specialized root organs, the so-called nodules, and infect the host plant via 
specific tubular structures called infection threads. Through the infection threads the bacteria are 
delivered into the nodule cells via an endocytic-like process and are then encapsulated into the 
symbiosome compartment (Jones et al., 2007). Once into the symbiosome, S. meliloti differentiates 
into the nitrogen-fixing bacteroid and persists leading to a symbiosis, a chronic intracellular host-
pathogen interaction (Gibson et al., 2008). The differentiation of S. meliloti from the free-living 
bacterial form in the bacteroid is mediated by a large family of legume nodule-specific cysteine-rich 
(NCR) peptides, which are released by the plant into the symbiosome compartment and may exhibit 
antimicrobial activity in vitro (Van De Velde et al., 2010). Recently it was demonstrated that BacA 
is essential for the survival of S. meliloti in M. truncatula symbiosomes and that its role is related to 
the ability of mediate the resistance of S. meliloti against the NCR AMPs produced by the plant and 
released into the symbiosome (Haag et al., 2011b). As these peptides damage the bacterial inner 
membrane, a model has been proposed in which SbmA/BacA may play a role in reducing the ability 
of NCR AMPs to induce membrane damage via two different mechanisms: i) SbmA/BacA may be 
directly involved in the uptake of NCR peptides, thus reducing their ability to disrupt the membrane 
integrity; ii) SbmA/BacA might confer protection by exporting NCR peptides outside the cell and 
therefore impairing the activity of these AMPs on intracellular targets. However further studies will 
be necessary to determine whether NCR AMPs act on intracellular targets and therefore whether 
their efflux would represent a mechanism of resistance.  
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Interestingly, in a mutant of M. truncatula, in which the trafficking of NCR peptides is impaired, a 
S. meliloti BacA-deficient mutant remained viable but was unable to develop into the persisting 
bacteroid form, thus indicating that SbmA/BacA is essential to guarantee the viability of the 
bacteria in presence of NCR AMPs and the consequent differentiation into bacteroids (Haag et al., 
2001b).  
On the basis of all these observations a model explaining the role of SbmA/BacA in bacteroid 
differentiation has been proposed. In a M. truncatula wild-type cell (Figure 1.8A), which produces 
NCR AMPs, only the wild-type S. meliloti remains viable in presence of the NCR peptides and is 
then able to develop the chronic infection, while the BacA-deficient mutant is challenged by the 
host NCR peptides and it is rapidly led to death. In contrast, in the M. truncatula mutant defective 
in the trafficking of NCR peptides (Figure 1.8B), both the wild-type and the BacA-deficient mutant 
of S. meliloti remain viable but none of them is able to differentiate in the persisting bacteroid.  
 
 
 
Figure 1.8. Schematic representation of the role of S. meliloti SbmA/BacA protein in the establishment of a 
chronic host-pathogen interaction in M. truncatula. A) M. truncatula wild-type cell. B) M. truncatula mutant 
defective in NCR peptides trafficking. (from Haag et al., 2011b).  
1.3.4. Regulation of the sbmA expression  
 
In E. coli the sbmA locus is under the control of the transcriptional regulator RpoE (σE) (Rezuchova 
et al., 2003; Rhodius et al., 2006; Bury-Moné et al., 2009) (Table 1). This transcriptional factor, 
together with other two signal transduction pathways, CpxRA (Conjugative Plasmid Expression) 
(Dorel et al., 2006) and BaeSR (Bacterial Adaptative Response), regulates genes involved in the 
envelope stress responses (Raivio and Silhavy, 2001; Raffa and Raivio, 2002).  
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Table 1. Function and genetic organization of new σE -dependent genes. Asterisks indicate the presence of an 
internal σE -dependent promoter; in all other cases promoters lie to the left of the leftmost gene (modified from 
Rezuchova et al., 2003).  
 
The activity of RpoE is negatively controlled by a membrane-bound anti-sigma factor RseA, which 
sequesters σE in unstressed cells (Figure 1.9). In response to outer membrane protein folding 
perturbations, RseA is proteolytically inactivated by the sequential action of the proteases DegS and 
YaeL. This releases σE into the cytoplasm where it can interact with the RNA polymerase core 
enzyme to regulate the target genes expression (Raivio and Silhavy, 2001; Alba et al., 2002).  
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Figure 1.9. Schematic representation of the σE -mediated pathway. Stresses such as heat lead to the accumulation of 
unassembled outer membrane porins (OMPs) and this activates the sequential proteolysis of the membrane-spanning 
anti-sigma RseA (Alba and Gross, 2004; Walsh et al., 2003). The inner membrane proteases DegS and RseP release the 
cytoplasmic portion of RseA, which will then be degraded by the cytoplasmic proteases ClpX and Lon (Flynn et al., 
2004) to release free σE which then binds to the RNA polymerase core in order to regulate the expression of target 
regulon members. σE upregulates functions required for synthesis, assembly, and/or insertion of both OMPs and LPS, as 
well as envelope-folding catalysts and chaperones. σE also regulates the expression of itself and its negative regulator 
RseA and enhances the expression of GreA and σ32. Finally, σE downregulates OMP expression, thereby reducing the 
accumulation of unassembled OMPs, which presumably limit the duration of the response (from Rhodius et al., 2006).  
 
The promoter strength properties of the complete σE regulon of E. coli have been determined and 
the sbmA promoter resulted to be a weak promoter in vitro while it showed a slightly higher activity 
in vivo (Mutalik et al., 2009; Rhodius and Mutalik, 2010).  
In agreement with these observations, recently it was shown that the expression of sbmA is affected 
by the tolC locus in a way dependent on the σE activity increase (Corbalàn et al., 2010). TolC forms 
a multifunctional outer membrane channel with roles in protein export and small noxious 
compounds efflux, mainly detergents and a wide range of antibacterial drugs (Nikaido, 1998; 
Thanassi and Hultgren, 2000). Under certain circumstances, the tolC mutants lack detectable levels 
of OmpF, a major porin protein of E. coli (Morona and Reeves, 1982), and show a modification in 
the OmpF/OmpC ratio, pushing it in favor of OmpC. The misregulation in the composition of the 
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outer membrane porins can act as a signal for the enhancement of σE activity and therefore reflect 
on changes in the expression levels of its downregulated genes. The observed upregulation of sbmA 
mediated by σE activation in response to the absence of tolC may be caused by the alteration in the 
outer membrane permeability and therefore it may be conjectured that the SbmA protein plays some 
role in offsetting a permeability defect of the outer membrane caused by the tolC mutation. All this 
implicates a potential copartecipation of both TolC and SbmA in order to solve a physiological 
problem in which the transport of SbmA-specific substrate could be necessary (Corbalàn et al., 
2010).  
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2. AIM OF THE STUDY 
Antimicrobial peptides represent a class of molecules widely studied because of their properties that 
make them good candidates to couple with the traditional antibiotics. Although most AMPs act 
permeabilizing the bacterial membrane, the class of the proline-rich peptides exert its antimicrobial 
activity without damaging the bacterial membrane and therefore the mechanism of action of these 
AMPs may be based on the protein-mediated internalization into the bacterial cytoplasm and the 
action on intracellular targets. One of the transporters involved in the uptake of the proline-rich 
peptides is the E. coli inner membrane protein SbmA, which is predicted to be the transmembrane 
domain of a putative ABC transport system.  
The aim of this thesis was to investigate the architecture of this protein and its function in the 
bacterial cell. As a first task, the binding of SbmA to its known substrate, the proline-rich peptide 
Bac7, was investigated in order to assess whether it requires a substrate-binding protein, as many 
ABC transporters, or it occurs directly. Second, the ability of SbmA to dimerize both in vitro and in 
vivo was investigated. As a third main task, our attention was focused on the source of energy 
necessary for the translocation of the substrate across the inner membrane, to determine whether it 
requires the ATP hydrolysis and therefore the presence of a nucleotide-binding domain.  
Moreover, with the aim of searching for putative SbmA-interacting partners that may represent the 
other subunits of the transport system and may help clarifying the physiological role of this protein 
in the bacterial cell, a proteomic approach was used to screen the whole proteome of E. coli against 
SbmA.  
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3. MATERIALS AND METHODS 
3.1. Bacterial cultures 
3.1.1. Microbiological Media 
 
Phosphate-buffered saline with 500 mM NaCl (HS-PBS) 
PBS was prepared by dissolving 1.2 g of Na2HPO4, 0.22 g of NaH2PO4•H2O and 23.4 g of NaCl in 
1 l of water. After sterilization in autoclave the solution was supplemented with sterile MgCl2 (final 
concentration: 10 mM). 
Luria-Bertani (LB) broth and Mueller-Hinton (MH) broth 
LB and MH broth were prepared from 25 g and 21 g of dehydrated medium (DIFCO), respectively, 
dissolved in 1 l of double-distilled water (MilliQ) and autoclaved. Solid LB and MH media were 
prepared using 15 g of agar as gelling agent per 1 l of appropriate medium. Approximately 15 ml of 
LB/MH-agar were shed into Petri dishes, left to solidify and stored at 4°C. 
Solid media with IPTG and X-gal 
Solid media were prepared following the instructions for the standard LB and MH solid media, then 
a solution of 100 µl of liquid LB Broth, 100 µl of X-gal 20 mg/ml and 10 µl of IPTG 100 µM was 
shed over the top of the solid medium, spread with a spatula and left to dry protected from light. 
SOB and SOC media 
To compose SOB medium, 20 g of bacto-tryptone, 5 g of yeast extract (DIFCO), and 0.5 g of NaCl 
were dissolved in 800 ml of water, 10 ml of 0.25 M KCl were added, pH was set to 7.0 using 1 M 
NaOH, the solution was then brought to 1 l and autoclaved. SOC medium was prepared by 
supplementing SOB with sterile MgCl2 and glucose at the final concentrations of 10 mM and 20 
mM, respectively. 
Antibiotics used in solid and liquid media 
Stock and final concentrations of antibiotics applied in the presented studies are shown in Table 1. 
 
Table 1. Antibiotics used in these studies.  
 
Stock solution 
Antibiotic 
Concentration Storage 
Concentration in the medium 
Ampicillin 100 mg/ml in water - 20°C 100 µg/ml 
Kanamycin 100 mg/ml in water - 20°C 50 µg/ml 
Tetracycline 15 mg/ml in 50% ethanol/water - 20°C 15 µg/ml 
Chloramphenicol 30 mg/ml in 100% ethanol -20°C 30 µg/ml 
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3.1.2. Bacteria growth conditions and storage 
 
Cultures on solid media were set up by spreading bacteria using inoculation loop or spreader and 
subsequent bottom-up overnight incubation of Petri plates in an incubator at 37°C. 
Liquid overnight (o/n) cultures were prepared by transferring a single colony of solid culture into 5 
ml of medium and approximately 18 h incubation at 37°C with shaking (140 RPM). 
When not specifically reported, refresh cultures were made by diluting an o/n culture 1:50 in the 
same medium and incubation at 37°C with shaking for approximately 2 h. The optical density of the 
culture was measured at the wavelength of 600 nm to ensure the mid-log phase of growth (OD600 
range: 0.3-0.5). Culture cell density (CFU/ml) was calculated by a standard growth curve 
determined before: OD600 0.31 = 4.6 × 107 CFU/ml. 
Isolated strains were stored at -80°C by adding 300 µl of 50% sterile glycerol solution in water to 
500 µl of o/n culture.  
3.2. Bacterial strains, plasmids and oligonucleotides 
 
The list of E. coli strains, plasmids and PCR primers used in the present work is presented in Table 
2.  
 
Table 2. Bacterial strains, plasmids and oligonucleotides used in this study. 
 
Strains, plasmids and 
oligonucleotides 
Characteristics or sequence Reference or source 
E. coli strains   
XL-1 Blue E. coli wild type strain Stratagene 
M15 E. coli wild type strain N/A 
BTH101 E. coli cya- strain Euromedex 
BW25113 E. coli wild type strain Genobase 
JW3710 E. coli BW25113 atpD::kmR mutant Keio Collection 
HB101 E. coli wild type strain DSMZ 
DH5α E. coli wild type strain N/A 
∆sbmA (JW0368) E. coli BW25113 sbmA::kmR mutant Keio Collection 
∆yaiW (JW0369) E. coli BW25113 yaiW::kmR mutant Keio Collection 
∆fieF (JW3886) E. coli BW25113 fieF::kmR mutant Keio Collection 
∆sbmA + fieF E. coli ∆sbmA (JW0368) carrying pUT18(fieF) plasmid This study 
∆sbmA + T18 E. coli ∆sbmA (JW0368) carrying pUT18 plasmid This study 
∆fieF + fieF E. coli ∆fieF (JW3886) carrying pUT18(fieF) plasmid This study 
∆fieF + T18 E. coli ∆fieF (JW3886) carrying pUT18 plasmid This study 
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NC122 E. coli SC122 ∆sbmA::lacZY Corbalàn et al., 2010 
NC322 E. coli CAG22222 ∆sbmA::lacZY Corbalàn et al., 2010 
SC122 E. coli wild type strain Cooper and Ruettinger, 1975 
CAG22222 SC122 rpoE::camR Rouviere et al., 1995 
Plasmids   
pBlueScript II KS (+) Cloning vector, AmpR Stratagene 
pQE-9 Expression vector, AmpR Qiagen 
pWaldo-GFPe Expression vector, KmR Provided by K. Beis 
pUT18 Expression vector, AmpR Euromedex 
pUT18C Expression vector, AmpR Euromedex 
pKT25 Expression vector, KmR Euromedex 
pKNT25 Expression vector, KmR Euromedex 
pUT18C(zip) GCN4 leucine zipper cloned in pUT18C Euromedex 
pKT25(zip) GCN4 leucine zipper cloned in pKT25 Euromedex 
pKNT25(sbmA) sbmA cloned BamHI-EcoRI in pKNT25 Provided by G. C. Walker 
pUT18(sbmA) sbmA cloned BamHI-EcoRI in pUT18 Provided by G. C. Walker 
pMAL-c2 Expression vector, AmpR New England Biolabs 
pMAL-c2(yaiW) yaiW cloned EcoRI-BamHI in pMAL-c2 This study 
pQE-9(yaiW) yaiW cloned PstI-EcoRI in pQE-9 This study 
pUT18(yaiW-66) yaiW cloned PstI-EcoRI in pUT18 (first 66 bp excluded) This study 
pUT18(yaiW) yaiW cloned PstI-EcoRI in pUT18 (full length) This study 
pUT18(fieF) fieF cloned BamHI-EcoRI in pUT18 This study 
Oligonucleotides   
MBP_yaiW fw 5’-CTGAATTCATGTCGCGCGTCAATC-3’ This study 
MBP_yaiW rev 5’-GCGGATCCTCACTGTTTCATACAACG-3’ This study 
yaiW fw 5’-ATCTGCAGATCGCGCGTCAATC-3’ This study 
yaiW rev 5’-CCGAATTCGACTGTTTCATACAACG-3’ This study 
yaiW -66 fw 5’-AACTGCAGAAGTCAGGCTCCGCAA-3’ This study 
fieF fw 5’-CGCGGATCCGAATCAATCTTATGG-3’ This study 
fieF rev 5’-CGCGAATTCGCTGAAAGCATAGACCGTT-3’ This study 
sbmA-yaiW fw 5’-CTGTTTAGCGCCGTACGGAAA-3’ This study 
sbmA-yaiW rev 5’-CGCTCGCTACATCTATCGCTT-3’ This study 
T18C fw 5’-ATGTACTGGAAACGGTGCCGG-3’ This study 
T18C rev 5’-CTTAACTATGCGGCATCAGAGC-3’ This study 
T18 fw 5’-GTGTGGAATTGTGAGCGGAT-3’ This study 
T18 rev 5’-TTCCACAACAAGTCGATGCG-3’ This study 
 
Keio Collection - Keio Collection of GenoBase (http://ecoli.aistnara.ac.jp/index.html)  
DSMZ - German Collection of Microorganisms and Cell Cultures 
N/A - not available 
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3.3. Microbiological assays 
3.3.1. Growth kinetics in presence of Bac7 
 
To determine the growth inhibition of the bacteria exposed to various peptide concentrations, we 
chose an OD-based approach of measuring the cell density changes over the incubation time on a 
microtiter plate. Mid-log phase E. coli cultures were diluted in MH Broth to 2 × 106 CFU/ml and 
100 µl of each dilution were added to 100 µl of peptide solutions, previously prepared on a 
microtiter plate, or to 100 µl of medium with no peptide, as a control. Thus suspensions of 106 
CFU/ml, with the peptide at half of the original concentration, were placed inside a plate reader 
(Tecan Sunrise, Switzerland) and incubated at 37°C with intermittent shaking. The OD was 
measured at 620 nm with 10-min intervals for 4 h (25 cycles). The data, performed in triplicate, 
were collected by Magellan 4 software (Tecan) and averaged. 
To test the effect of the zinc on the bacterial susceptibility to Bac7, the o/n bacterial suspension was 
diluted 1:50 into fresh MH Broth and grown 1 hour at 37°C with shaking and then an additional 1 
hour in presence of 1 mM ZnCl2. The bacterial cultures were then diluted to 2 × 106 CFU/ml and 
the assay performed as described above.  
3.3.2. Flow cytometry assays 
 
The uptake of BODIPY-labelled Bac7(1-35) in E. coli cells was determined by flow cytometry 
using a Cytomics FC 500 instrument (Beckman-Coulter, Inc.) equipped with an argon laser (488 
nm, 5 mW) and a photomultiplier tube fluorescence detector for green (525 nm) filtered light. All 
detectors were set to the logarithmic amplification. Optical and electronic noise were eliminated by 
setting the electronic gating threshold on the forward-scattering detector, while the data flow rate 
was kept below 300 events per second to avoid cell coincidence. At least 10,000 events were 
acquired for each sample.  
A standard o/n culture was prepared in MH Broth and then diluted 1:50 in fresh medium and left to 
grow two hours at 37°C with shaking. After two hours the OD600 was measured, bacterial 
suspensions were diluted to 1 × 106 cells/ml and 1 ml of the suspension was incubated with 0.25 
µM Bac7(1-35)-BY for 10 or 60 minutes at 37°C. Bacteria were then collected at 10,000 rpm for 5 
minutes and the pellet was washed three times with Phosphate-Buffered-Saline High Salts (PBS-
HS). Finally bacteria were resuspended in 1 ml of PBS HS and assayed by flow cytometry 
according to the protocol established in Benincasa et al., 2009. Data analysis was performed with 
the FCS express V3 software (De Novo Software, CA).  
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For the uptake assay in presence of different inhibitors 5 mM 2,4-dinitrophenol (DNP), 5 mM 
sodium arsenate or both of them were added to the 1 ml bacterial suspension in presence of 0.25 
µM Bac7(1-35)-BY for 10 minutes at 37°C. For the uptake assay with E. coli BW25113 and 
∆SbmA strains after induction with ZnCl2, the o/n preculture was diluted 1:50 in fresh medium and 
left to grow one hour at 37°C. Then the bacterial suspension for each strain was divided into two 
tubes with 7 ml each and ZnCl2 to the final concentration of 1 mM was added only to one of the 
two, corresponding to the bacterial suspension induced with zinc. Both tubes were left to grow one 
hour at 37°C and then diluted to 1 × 106 cells/ml as described above.  
 
Solutions and Reagents 
 
Phosphate-Buffered-Saline High Salts (PBS-HS): 500 mM NaCl in PBS.  
3.3.3. ATP determination 
 
To determine the total amount of ATP in E. coli BW25113 and JW3710 cells the commercially 
available ATP Determination kit (Invitrogen) was used. Bacterial suspensions were prepared as 
described for the flow cytometry assays but the fluorescent Bac7(1-35)-BY was not added. After 
the 10 minutes incubation at 37°C with the different inhibitors, 100 µl of each bacterial suspension 
were transferred to a fresh 2 ml tube and 900 µl of boiling Tris-EDTA Buffer were added to each 
tube. The tubes were then incubated at 100°C for 2 minutes and then centrifuged at 10,000 rpm for 
2 minutes. 100 µl of each sample were assayed in triplicate with a luminometer (Hidex Chamaleon).  
 
Solutions and Reagents 
 
Tris-EDTA Buffer: 100 mM Tris-HCl pH 7.75, 4 mM EDTA.  
3.3.4. Analysis of the effect of ZnCl2 on SbmA expression 
 
Bacterial suspensions were grown o/n in 5 ml of LB Broth with the appropriate antibiotic at 30°C 
and then diluted 1:20 into fresh medium and grown one hour at 30°C. Afterwards, each bacterial 
suspension was divided into 6 tubes of 10 ml each and ZnCl2 to the desired final concentration was 
added to each tube (ranging from 0 to 1.25 mM). Bacterial suspensions were then grown for 
additional 30 minutes at 30°C and then the OD600 for each tube was measured. 1 ml of each 
bacterial suspension was pelletted in a 2 ml tube by centrifugation at 9,000 rpm for 5 minutes and 
resuspended in the appropriate volume of 1 × Sample Buffer in order to normalize the concentration 
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of cells per ml. Bacteria were then lysed by freezing them at -20°C, sonicating 10 seconds and 
heating them at 80°C for 10 minutes. Each sample was then spinned down and loaded onto an SDS-
PAGE gel following the procedure described in Section 3.7. 
 
Solutions and Reagents 
 
1 × Sample Buffer: 3% SDS (w/v), 0.1 M DTT, 7.5% glycerol (w/v), 0.0125% bromophenol blue in 
0.125 M Tris-HCl pH 6.8. 
3.4. Expression and purification of recombinant proteins 
3.4.1. Expression of recombinant SbmA 
 
To express the recombinant SbmA, a single colony of E. coli XL-1 Blue transformed with pQE-
9(sbmA) was inoculated into 5 ml of liquid LB Broth with the appropriate antibiotic and grown with 
shaking at 37°C o/n. The o/n culture was diluted 1:50 into two flasks of 500 ml each of fresh 
medium and left to grow with shaking at 37°C until the OD600 reaches 0.7-0.8. At this point the 
bacterial suspension was induced with IPTG at the final concentration of 1 µM and left to grow o/n 
with shaking at 30°C.  
The next day the whole bacterial suspension was pelletted into 4 tubes of 50 ml by means of a 
repeated centrifugation step at 4,000 rpm for 10 minutes and the surnatant was discarded. The pellet 
was resuspended with 12 ml of ice-cold Lysis Buffer and left at 4°C with stirring for 10 minutes. 
The samples were then sonicated three times for 10 seconds each time with a Branson sonicator 
(Branson SONIC Power S75) at 2.5 D.C. Amperes. Samples were then centrifuged at 4°C at 10,000 
rpm for 20 minutes and the surnatants were stored at -20°C.  
 
Solutions and Reagents 
 
Lysis Buffer: 20 mM Tris-HCl pH 7.5, 100 mM NaCl, 1% Triton X-100. 
3.4.2. Expression of recombinant YaiW 
 
To express the recombinant YaiW, two different expression systems were used.  
In the case of the first one, a single colony of E. coli M15 transformed with pQE-9(yaiW) was 
inoculated into 5 ml of liquid LB Broth with the appropriate antibiotic and grown with shaking at 
37°C o/n. The o/n culture was diluted 1:20 into two flasks of 500 ml each of fresh medium and left 
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to grow with shaking at 37°C until the OD600 reaches 0.6-0.7. At this point the bacterial suspension 
was induced with IPTG at the final concentration of 10 µM and left to grow 6 hours with shaking at 
RT. The next day the whole bacterial suspension was pelleted into 4 tubes of 50 ml by means of a 
repeated centrifugation step at 4,000 rpm for 10 minutes and the surnatant was discarded. The 
bacterial pellet at the bottom of each tube was resuspended with 12 ml of ice-cold Lysis Buffer and 
left at 4°C with stirring for 10 minutes. The samples were then sonicated three times for 10 seconds 
each time with a Branson sonicator (Branson SONIC Power S75) at 2.5 D.C. Amperes. Samples 
were then centrifuged at 4°C at 10,000 rpm for 20 minutes and the surnatants were stored at -20°C. 
In the case of the second expression system, a single colony of E. coli XL1-Blue transformed with 
pMAL-c2(yaiW) was inoculated into 5 ml of liquid LB Broth with the appropriate antibiotic and 
grown with shaking at 37°C o/n. The o/n culture was diluted 1:25 into two flasks of 500 ml each of 
fresh medium and left to grow with shaking at 37°C until the OD600 reaches 0.6-0.7. At this point 
the bacterial suspension was induced with IPTG at the final concentration of 10 µM and left to grow 
o/n with shaking at RT. The next day the whole bacterial suspension was pelleted into 4 tubes of 50 
ml by means of a repeated centrifugation step at 4,000 rpm for 10 minutes and the surnatant was 
discarded. The bacterial pellet at the bottom of each tube was resuspended with 12 ml of ice-cold 
Lysis Buffer and left at 4°C with stirring for 10 minutes. The samples were then sonicated three 
times for 10 seconds each time with a Branson sonicator (Branson SONIC Power S75) at 2.5 D.C. 
Amperes. Samples were then centrifuged at 4°C at 10,000 rpm for 20 minutes and the surnatants 
were stored at -20°C. 
3.4.3. Purification of recombinant SbmA 
 
The recombinant SbmA was purified from the surnatant of the induced cell lysate by means of 
affinity chromatography on the Ni-NTA resin (Invitrogen), taking advantage of the 6×His tag at the 
N-terminus of the protein. The Ni-NTA resin was equilibrated with P1 Buffer containing 5 mM 
imidazole and a stock solution of imidazole 2 M was added to the bacterial lysate to a final 
concentration of 5 mM in order to keep it at the same concentration of imidazole in P1 Buffer. After 
that, the bacterial lysate was loaded onto the resin with a lysate:resin ratio of 8:1 and the column 
was incubated at 4°C with agitation for 15 minutes. At the end of the incubation, the flow-through 
was collected and stored for further analysis. The resin was then washed three times with P1 Buffer 
containing 5 mM imidazole and incubated with a solution of 25 mM imidazole, 25% glycerol, 5% 
ethanol in P1 Buffer for 15 minutes at 4°C with agitation. At the end the flow-through was 
collected, stored for further analysis and the resin was washed six times with the same solution. The 
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flow-through of the sixth wash was collected and stored to be subsequently analysed in order to 
check the goodness of the washing step.  
After the washing step, the protein was eluted with P1 Buffer containing 100 mM imidazole. The 
eluted protein was collected after 15 minutes of incubation at 4°C with shaking, the Ni-NTA resin 
was washed two times with the same buffer and the washes were collected and stored  at -20°C for 
further analysis.  
 
Solutions and Reagents 
 
P1 Buffer: 20 mM Tris-HCl pH 8, 1 M NaCl, 5 mM β-mercaptoethanol, 1% Triton X-100. 
Imidazole stock solution: 2M in water.  
3.4.4. Purification of recombinant YaiW 
 
The recombinant YaiW protein was purified from the surnatant of the induced cell lysate on the 
amylose-resin (New England Biolabs), taking advantage of the fusion with the Maltose Binding 
Protein. The amylose resin (400 µl) was equilibrated with Buffer A and washed twice in the same 
buffer, in parallel the surnatant of the induced cell lysate was diluted 1:5 in the same buffer in order 
to reduce the amount of detergent down to 0.2%, to avoid any interpherence with the binding of the 
recombinant protein to the resin. 10 ml of the diluted lysate were divided into two aliquots and 
incubated for 15 minutes per each at 4°C on rocking. Finally the resin was washed three times with 
Buffer A and resuspended with 400 µl of the same buffer, then the protein was eluted with a 10 mM 
maltose solution in Buffer A and the fractions were collected and analyzed by SDS-PAGE.  
 
Solutions and Reagents 
 
Buffer A: 20 mM Tris-HCl pH 7.5, 100 mM NaCl. 
3.4.5. Desalting of the purified recombinant protein 
 
To get rid of salts and the other small-size molecules, the purified protein was submitted to gel 
filtration onto the Sephadex G-25 resin (GE Healthcare). The resin was equilibrated with the D 
Buffer and then the purified protein sample was loaded onto the resin, the fractions were eluted with 
the D Buffer, collected into 1.5 ml tubes and stored at -20°C to be analyzed by SDS-PAGE.   
 
Solutions and Reagents 
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D Buffer: 20 mM Tris-HCl pH 7.5, 100 mM NaCl, 0.5% Triton X-100.   
3.4.6. Protein quantification 
 
Concentrations of the proteins were determined by the BCA assay kit (Pierce) using BSA protein to 
design a standard curve. 
3.5. Peptide preparation 
3.5.1. Synthesis and purification 
 
The peptides Bac7(1-16) and Bac7(1-35) were synthesized in our laboratory according to Mattiuzzo 
et al., 2007.  
3.5.2. Fluorescent labelling of Bac7(1-35) 
 
Bac7(1-35) was fluorescently labelled via linkage of the thiol-reactive fluorescent dye BODIPY® 
FL N-(2-aminoethyl) maleimide (Invitrogen) to an ad hoc added C-terminal cysteine residue. 
Peptide labelling was carried out in 10 mM sodium-phosphate buffer, pH 7.4, containing 30% of 
acetonitrile. In brief, 2 ml of a 1 mg/ml solution of the fluorescent dye dissolved in 100% 
acetonitrile were added dropwise to 18 ml of a 0.1 mg/ml peptide solution under nitrogen bubbling 
and stirring in the dark. After 2 hours of incubation at RT in the dark with stirring, a new aliquot of 
2 mg of the peptide was added to the same solution and left o/n in the dark at 4°C with stirring. The 
excess of thiol-reactive reagent was then scavenged by the addition of a 10-fold excess of cysteine. 
After 1 hour of incubation at RT with stirring, the pH of the solution was adjusted to pH 2.5-3 and 
the labelled peptide was diluted with Solvent A (0.05% TFA in H2O) to 5-10% of acetonitrile, 
filtered and purified using the procedure described above.  
3.5.3. Peptide quantification 
 
To estimate peptide concentration, the Waddell assay was used (Waddell, 1956). The analysis was 
conducted in a quartz cuvette (path length 10 mm; vol. 1 ml) by adding 2.5 µl of peptide solution to 
the blank (1 ml of 1/300 N NaOH), reading OD at the wavelengths of 215 nm and 225 nm, 
subtracting OD225 from OD215 and multiplying the difference by the dilution factor (400). The 
addition of another 2.5 µl of peptide solution was followed by the same procedure (multiplier: 200) 
and the two results were then normalized and averaged. Aliquots of a different batch of Bac7(1-35) 
or Bac7(1-16) were used as references. Each estimation was performed in duplicate and averaged. 
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The values calculated for the evaluated peptide were referred to those of the reference peptide with 
a known concentration, expressed in mg/ml. 
3.6. Affinity chromatography assays 
3.6.1. Affinity chromatography with purified SbmA onto Bac7-functionalized resin 
 
With the aim of immobilizing it onto the Sulfolink resin (Pierce), Bac7(1-35) was synthesized with 
an extra cysteine at the C-terminus. 0.5 mg of lyophilized peptide was dissolved in 2 ml of 
Coupling Buffer and the sulfhydryl groups were reduced by adding tris(2-carboxyethyl)phosphine 
(TCEP) at the final concentration of 25 mM and incubating the mixture at RT with shaking for 30 
minutes, meanwhile 1 ml of the Sulfolink resin (slurry) was equilibrated in the Coupling Buffer. 
Then the peptide was loaded onto the column, after having displaced oxygen by nitrogen flow, and 
incubated at RT with shaking for 1 hour. The surnatant was collected and stored for the 
quantification of the unbound peptide, while a second aliquot of lyophilized peptide was loaded 
onto the column. After this second step of coupling, the surnatant was collected and the resin was 
washed three times with a 1 M NaCl solution and then other two times with the Coupling Buffer. 
To block the non-specific binding sites, a solution of 50 mM cysteine in Coupling Buffer was 
loaded onto the resin and incubated at RT with shaking for 45 minutes, the surnatant was collected 
and the resin was washed three times with phosphate-buffered-saline (PBS). To prepare the column 
for storage, the column was equilibrated with phosphate-buffered-saline with 0.05% sodium azide, 
then washed three times with the same solution and stored at 4°C.  
25 µl of the resin prepared in the previous step were equilibrated at RT with the appropriate 
Binding/Washing Solution (the same used to purify the protein) and then 60 µl of a solution of the 
protein purified in our laboratory at a final concentration of  0.5 mg/ml or 15 µl of the protein 
purified by K. Beis (MPL, Imperial College, London) at a final concentration of 2 mg/ml was added 
onto the Bac7(1-35)-linked resin and incubated while rocking o/n at 4°C. After the incubation the 
resin was centrifuged at 1,000×g for 1 minute and the surnatant was recovered for the quantification 
of the unbound protein. The resin was then washed three times with the appropriate 
Binding/Washing Solution and the protein bound to the peptide was eluted by the addiction of 25 µl 
of Sample Buffer 4× to the resin and by heating at 60°C for 10 minutes.  
 
Solutions and Reagents 
 
Coupling buffer: 50 mM Tris-HCl pH 8.5, 5 mM EDTA-Na. 
L-Cysteine in Coupling Buffer: 50 mM L-Cysteine•HCl.  
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Phosphate-Buffered-Saline (PBS): 1.59 mM NaH2PO4, 8.45 mM Na2HPO4, 150 mM NaCl pH 7.4. 
TCEP Stock: 0.5 M TCEP at neutral pH. 
Binding/Washing Solution (SbmA of our laboratory): Tris-HCl 20 mM pH 7.5, NaCl 100 mM, 
0.5% Triton X-100. 
Binding/Washing Solution (SbmA obtained by K. Beis): Tris-HCl 20 mM pH 7.5, NaCl 150 mM, 
0.03% n-dodecyl β-D-maltoside (DDM). 
Sample Buffer 4×: 12% SDS (w/v), 0.4 M DTT, 30% glycerol (w/v), 0.05% bromophenol blue in 
0.5 M Tris-HCl pH 6.8.   
3.6.2. Affinity chromatography with purified SbmA onto YaiW-linked resin 
 
With the aim of immobilizing the YaiW-MBP fusion to the amylose-resin, 200 µl of resin (slurry) 
were transferred to a 1.5 ml tube and equilibrated with Buffer A. In parallel the bacterial lysate 
corresponding to the soluble fraction of E. coli XL1-Blue transformed with pMAL-c2(yaiW) was 
diluted 1:5 with Buffer A and aliquots of 1 ml per each were incubated with the amylose-resin for 
15 minutes at 4°C. After each incubation, the tube was centrifuged at 10,000 rpm 1 minute and the 
surnatant was collected. Finally the resin was washed three times with Buffer A and 50 µl were 
picked up and transferred to a clean 1.5 ml tube in order to check the binding of the YaiW-MBP 
fusion to the resin. The sample was then centrifuged at 10,000 rpm 1 minute, the surnatant was 
discarded, 50 µl of 1 × Sample Buffer were added to the resin and the sample was heated 10 
minutes at 60°C. The remaining 150 µl of the YaiW-linked resin were incubated with 250 µl of a 
solution of purified SbmA at a concentration of 0.1 mg/ml, diluted in order to reduce the amount of 
detergent down to 0.2%, for 1.5 hours at 4°C. After the incubation, the tube was centrifuged at 
10,000 rpm for 1 minute and the surnatant was collected for further analysis (unbound SbmA). The 
resin was then washed three times with Buffer A, resuspended with 150 µl of 1 × Sample Buffer 
and heated 10 minutes at 60°C. For the affinity chromatography with SbmA in the dimeric state, the 
crosslinking was performed as described in Section 8 with 0.25% of glutaraldehyde and then the 
crosslinked protein was incubated with the YaiW-linked resin.  
 
Solutions and Reagents 
 
Buffer A: 20 mM Tris-HCl pH 7.5, 100 mM NaCl. 
1 × Sample Buffer: 3% SDS (w/v), 0.1 M DTT, 7.5% glycerol (w/v), 0.0125% bromophenol blue in 
0.125 M Tris-HCl pH 6.8. 
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3.7. Analysis of proteins 
3.7.1. SDS-PAGE Analysis 
 
The expression of the proteins was analyzed in the presence of denaturing conditions on a gel with a 
thickness of 0.75 mm and prepared with a percentage of acrylamide of 12.5% for the separation 
(Resolving gel) and of 4% for the loading (Stacking gel). The solutions for the Resolving and 
Stacking gels were prepared as described in Table 3.  
 
Table 3. List of reagents and volumes used to prepare SDS-PAGE gels. 
 
Stacking gel (4%)  Final volume 5 ml Resolving gel (12.5%) Final volume 10 ml 
40% acrylamide solution 0.5 ml 40% acrylamide solution  3.14 ml 
4× Stacking gel buffer 1.25 ml 4× Resolving gel buffer 2.5 ml 
10% SDS 0.05 ml 10% SDS 0.1 ml 
water 3.16 ml water 4.21 ml 
10% APS 25 µl 10% APS 50 µl 
TEMED 2.7 µl TEMED 3.7 µl 
 
The gel was then assembled into a vertical electrophoresis system (Biorad) and covered with the 
Running Buffer. Protein samples were prepared by the addiction of ¼ of Sample Buffer 4×, heating 
for 10 minutes at 80°C and then loaded onto the gel (usually 10-15 µl per each well). The run was 
performed at 50 V for 30 minutes and at 200 V for 50 minutes.  
Gels were stained for 1-2 hours in the Coomassie Staining Solution with shaking and then rinsed 
with water and destained for 1 hour in the Destaining Solution with shaking.   
Alternatively gels were stained as follows. The gel was left in the Fixing Solution for 20 minutes, 
then the solution was discarded and the gel left for others 20 minutes in freshly added Fixing 
Solution. After this step the gel was rinsed two times with a 10 minutes wash in water per each and 
then left in the Sensitizing Solution for 10 minutes. The gel was rinsed two times with a 5 minutes 
wash in water per each and then left in the Silver Solution for 10 minutes. The Silver Solution was 
discarded, the gel was washed 1 minute with water and left in the Developing Solution until protein 
bands become visible, at this point the Stop Solution was added and the gel was left in this solution 
for 5 minutes. At the end of the procedure, the gel was rinsed with water.  
 
Solutions and Reagents 
 
Resolving gel buffer 4×: 1.5 M Tris-HCl pH 8.8.  
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Stacking gel buffer 4×: 0.5 M Tris-HCl pH 6.8.  
Running buffer 5×: 0.125 M Tris, 0.96 M glycine pH 8.3, 0.5% SDS.   
Sample Buffer 4×: 12% SDS (w/v), 0.4 M DTT, 30% glycerol (w/v), 0.05% bromophenol blue in 
0.5 M Tris-HCl pH 6.8   
Coomassie Staining Solution: 0.05% (w/v) Blue Coomassie, 10% (v/v) acetic acid, 50% (v/v) 
ethanol. 
Destaining Solution: 10% (v/v) acetic acid, 40% (v/v) ethanol. 
Fix Solution: 30% (v/v) ethanol, 5% (v/v) acetic acid. 
Sensitizing Solution: 30% (v/v) ethanol, 6.8% (w/v) sodium acetate, 0.2% (w/v) sodium thiosulfate, 
0.125% (v/v) glutaraldehyde.  
Silver Solution: 0.25% (w/v) silver nitrate, 0.015% (v/v) formaldehyde.  
Development Solution: 2.5% (w/v) sodium carbonate, 0.0074% (v/v) formaldehyde. 
Stop Solution: 1.5% (w/v) Na2EDTA.  
3.7.2. Western blot analysis 
 
After the separation by SDS-PAGE, the protein samples were immobilized on a nitrocellulose sheet 
and incubated with specific antibodies. For this study two different primary antibodies were used, 
the commercially available anti-His tag antibody (Amersham) and the anti-SbmA antibodies against 
two different epitopes of the protein purified in our laboratory (see Section 3.7.3.). After the SDS-
PAGE both the gel and the nitrocellulose sheet were equilibrated for 15 minutes in Towbin Buffer, 
in parallel with six sheets of paper (Whatman 3 mm) and then the sandwich was assembled on the 
Transblotter (BioRad Transblot semi-dry transfer cell). The transfer was performed at 20 V for 30 
minutes and then the nitrocellulose membrane was left in the Ponceau Solution for an additional 15 
minutes, then rinsed with water and left to dry.  
For the detection with the antibodies, the membrane was incubated o/n in Blocking Solution at 4°C 
and then incubated for 1.5 hours at RT in agitation with the primary antibody at the appropriate 
dilution (1:2000 for both the anti-His tag and the anti-SbmA antibodies). The membrane was then 
washed three times with the Blocking Solution for 5 minutes each and incubated for 1 hour at RT in 
agitation with the appropriate secondary antibody at the dilution 1:2000, the anti-mouse IgG HRP-
conjugated antibody (Amersham) for the primary anti-His tag antibody and the anti-rabbit IgG 
HRP-conjugated antibody (Sigma-Aldrich) for the primary anti-SbmA antibody. The membrane 
was washed three times with the Blocking Solution for 5 minutes each and then other two times 
with the TBST Solution. The detection of the chemiluminescence was performed using the 
commercially available kit ECL Plus Western Blotting Detection Reagent (Amersham).  
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Solutions and Reagents 
 
Towbin buffer: 25 mM Tris, 0.192 M glycine, 20% (v/v) methanol. 
Ponceau Solution: 0.1% Ponceau powder in acetic acid 1% in water.  
TBST Solution: 40 mM Tris-HCl pH 7.5, 200 mM NaCl, 0.1% (v/v) Tween 20. 
Blocking solution: 5% milk powder in TBST Solution. 
3.7.3. Purification of the anti-SbmA antibodies 
 
To purify polyclonal antibodies from rabbit antisera, two different peptides corresponding 
respectively to the 381-400 and 269-292 fragments of the SbmA amino acid sequence were 
previously synthesized with an extra cysteine residue added at their C-terminal and conjugated with 
the sulfhydryl-reactive keyhole limpet hemocyanin (KLH) (Pierce). The two peptides conjugated 
with the KLH were then used to stimulate the production of specific antibodies by two different 
rabbits. Different antisera were analyzed in order to choose the best one to purify the specific 
antibodies and the fifth was selected to carry on the whole procedure.  
The two peptides, corresponding respectively to the 381-400 and 269-292 sequence of SbmA, were 
immobilized onto the Sulfolink resin (Pierce) via their C-terminally added cysteine residue 
following the procedure described in Section 3.6.1. and the resins were then stored in PBS at 4°C 
until use.  
The entire procedure to purify the two anti-SbmA antibodies was performed at 4°C to preserve their 
integrity. The two different antisera were centrifuged at 6,000 rpm for 10 minutes at 4°C and the 
surnatants were filtered with a 0.2 µm filter into a 50 ml tube per each. The filter was then washed 
with one volume of PBS in order to dilute 1:1 in PBS each antiserum and 1 ml of the appropriate 
peptide-linked resin (slurry) was added to each antiserum and left o/n with rocking at 4°C. The day 
after, the two suspensions were transferred to two new columns in order to pack the resin and the 
recovered flow-through was used to wash the tubes to ensure that all the resin beads have been 
transferred to the column. The two columns with the bound antibody were washed five times with 
PBS and the first 2 ml of the washes were collected in the same tubes containing the flow-though. 
Then the columns were washed other three times with PBS HST, three times with PBS HS, five 
times with PBS and three times with saline. To elute the antibody from the resin an acid solution of 
glycine was used: the different elution fractions were collected and the pH of the fractions likely 
corresponding to the purified antibody was immediately checked and adjusted to pH 7.5 with an 
alkaline solution. The columns of the two resins were washed with PBS three times and stored in 
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PBS with 0.05% sodium azide at 4°C, while the fractions of the purified antibody were submitted to 
the BCA assay (see Section 3.4.6.) to measure their concentrations and then stored at -20°C with 
30% glycerol.  
 
Solutions and Reagents 
 
SbmA(381-400):  SIYKRLRSFEHELDGDKIQEC. 
SbmA(269-292):  EFKNQRVEAAYRKELVYGEDDATRC. 
Phosphate-Buffered-Saline (PBS): 1.59 mM NaH2PO4, 8.45 mM Na2HPO4, 150 mM NaCl pH 7.4. 
PBS HST: 500 mM NaCl, 0.1% Triton X-100 in PBS. 
PBS HS: 500 mM NaCl in PBS. 
Saline: 0.9% NaCl. 
Acid Solution: 200 mM glycine-HCl pH 2.8. 
Alkaline Solution: 2M Tris-HCl pH 8. 
3.8. In vitro cross-linking assay 
 
The purified SbmA protein (~ 6 µg) was incubated with increasing concentrations of glutaraldehyde 
(0.125, 0.25, 0.5%) for 10 minutes at 4°C in a total reaction volume of 20 µl, then a stock solution 
of glycine 1.25 M was added to a final concentration of 0.125 M and the sample was incubated 10 
minutes at 4°C in order to block the reaction. The samples were then prepared for SDS-PAGE and 
Western blot analyses as described in Section 3.7.  
3.9. In vivo bacterial two-hybrid experiments 
3.9.1. Preparation of competent cells 
 
To prepare competent cells of E. coli BTH101 strain, a standard o/n culture in LB broth was 
prepared and refreshed the following day in 200 ml of medium, up to an OD600 range of 0.5-0.7. 
The culture was transferred into four 50 ml tubes, cooled down on ice for 30 min and centrifuged at 
1,800 g at 4°C, for 15 min, and the medium was discarded. The remaining bacteria pellet was 
washed twice in 25 ml of sterile water and centrifuged, and the supernatant was discarded. The cells 
were resuspended in 10 ml of sterile 10% glycerol and centrifuged. Finally, the bacteria were 
resuspended in 1 ml of sterile 10% glycerol, distributed into several 1.5 ml tubes and stored at -
80°C. The rate of competence was verified with a test transformation. 50 µl of freshly thawed 
competent cell suspension were mixed with 1 µl of the pUC18 plasmid solution at a known 
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concentration (100 ng/µl), transferred into an electroporation cuvette, placed in the electroporator 
(MicroPulser, Biorad) and exposed to an electric discharge (1.8 kV, 5 ms). Immediately afterwards, 
950 µl of SOC medium were added and the cell suspension was incubated at 37°C for 1 hour. 
Finally, the cells were diluted, plated on LB agar with ampicillin and the colonies were counted. 
The rate of competence was expressed as the number of transformed cells per 1 µg of the plasmid 
and a value of 108/ µg was considered sufficient. 
3.9.2. Co-transformation of BTH101 competent cells 
 
Competent cells were electroporated as described above with 1 µl of DNA at a concentration of 10 
ng/µl. The co-transformants were plated on LB agar plates with X-Gal and IPTG containing 
kanamycin (50 µg/ml) and ampicillin (100 µg/ml) and left to grow at 30°C for 48 hours. Clones 
were considered positives when the intensity of the blue color was comparable to that of the 
positive control, represented by the two leucine zipper domains of the transcriptional factor GCN4 
of Saccharomyces cerevisiae. In the case of the genomic library, positive clones were picked up and 
grown o/n in 5 ml of LB Broth with ampicillin and kanamycin at 30°C. The plasmids were 
extracted using the EuroGOLD Plasmid Miniprep Kit (Euroclone) and sent to BMR Genomics to be 
sequenced. In parallel from the o/n suspension of each positive clone a glycerol stock was prepared 
and stored at -80°C.   
3.10. β-galactosidase assays 
 
To test the activity of the reconstituted β-galactosidase a single colony picked up from the plate of 
the co-transformants was inoculated in 5 ml of LB Broth containing kanamycin (50 µg/ml) and 
ampicillin (100 µg/ml) and left to grow o/n at 30°C with shaking. The o/n suspension was diluted 
1:20 into fresh medium containing kanamycin (50 µg/ml), ampicilline (100 µg/ml) and IPTG 5 µM 
and left 2 hours at 30°C with shaking. The suspensions were then cooled down on ice to block the 
growth and 2 ml of each bacterial suspension were transferred to a 2 ml tube, centrifuged at 10,000 
rpm for 10 minutes and resuspended with 2 ml of Z-Buffer with β-mercaptoethanol. The OD600 of 
each sample in Z-Buffer with β-mercaptoethanol was then measured and 0.6 ml of each suspension 
were transferred to a fresh tube and submitted to the permeabilization step with 24 µl of 0.1% SDS 
and 48 µl of chloroform. The tubes were then vortexed 10 seconds and incubated at 37°C for 20 
minutes. Finally 100 µl of each sample, in triplicate, were transferred to a 96-wells microtiter and 
20 µl of pre-incubated 0.4% o-nitrophenyl-β-D-galactoside (ONPG) in Z-Buffer without β-
mercaptoethanol were added to each well. The microtiter was then incubated at 37°C until the 
yellow color appears and the reaction was stopped by the addiction of 50 µl of 1 M Na2CO3. The 
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OD420 was measured in 1 hour and the β-galactosidase activity was calculated in M.U. following the 
reported formula:  
M.U. = 1000 × OD420 / t × v × OD600 
 
OD420 = absorbance of the yellow o-nitrophenol 
OD600 = reflects cell density 
t = reaction time in minutes 
v = volume of bacterial suspension assayed in milliliters 
 
For the assay to test the dimerization of SbmA in presence of ZnCl2, the o/n bacterial suspension 
was diluted 1:20 into fresh medium containing kanamycin (50 µg/ml), ampicillin (100 µg/ml) and 
IPTG 5 µM and left one hour at 30°C with shaking. Afterwards the bacterial suspension was 
divided into two tubes with 7 ml each and a solution of ZnCl2 was added only to one of the two at 
the final concentration of 1 mM. The tubes were then incubated at 30°C for 30 minutes, cooled on 
ice to stop the growth and then the above described procedure was applied. 
To test the transcriptional activity of the sbmA promoter in presence and absence of the 
transcriptional regulator RpoE, the E. coli NC122 and NC322 strains, generously provided by our 
collaborator P. A. Vincent (InsiBIO, San Miguél de Tucumàn, Argentina), were used. For the assay 
on bacteria in exponential phase, a standard o/n preculture was set up in LB Broth with the 
appropriate antibiotics and left to grow at 30°C. The o/n preculture for each strain was then diluted 
1:20 into fresh medium, left to grow with shaking at 30°C until the OD600 reaches 0.2-0.3 and then 
divided into 6 tubes of 10 ml each with increasing concentrations of ZnCl2 (ranging from 0 to 1.25 
mM) and incubated at 30°C for 30 minutes. Afterwards the bacterial suspensions were cooled down 
on ice and the procedure described above was applied. For the assay on bacteria in stationary phase, 
the bacterial suspensions were left to grow until the OD600 reaches 0.9-1 and then assayed following 
the usual procedure. 
 
Solutions and Reagents 
 
Z-Buffer: 60 mM Na2HPO4, 40 mM NaH2PO4, 10 mM KCl, 1 mM MgSO4, 0.05 M β-
mercaptoethanol pH 7.0  
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3.11. Molecular biology techniques 
3.11.1. RT-PCR of the sbmA-yaiW intergenic region 
 
Total RNA of E. coli HB101 was extracted from a bacterial cell sample of 109 cells harvested at  an 
OD600 of 0.4 according to the User Manual of the Pure Link RNA Mini kit (Invitrogen) and stored 
at -20°C for further processing. The concentration of the extracted RNA was measured by the 
spectrophotometer and approximately 4 µg of RNA were treated with 4 µl of RQ1 RNAse-free 
DNAse (Promega) according to the User Sheet. After the treatment with the DNAse the 
concentration of the RNA sample was measured again by the spectrophotometer and the sample 
was prepared for electrophoresis by adding 1/6 of the 6 × Loading Buffer and heating for 5 minutes 
at 68°C. The sample was then loaded onto a 1.2% denaturing agarose gel (prepared as described in 
Table 4) and the run was performed at 50 V for two hours.  
 
Table 4. List of reagents and volumes used to prepare the agarose gel for RNA analysis. 
 
Reagent Final volume 40 ml 
Agarose (1.2% final) 0.48 g 
diethylpyrocarbonate (DEPC)-treated water 33.6 ml 
10 × 3-(N-morpholino)propanesulfonic acid (MOPS) Buffer 4 ml 
37% formaldehyde 2.4 ml 
 
cDNA was synthesized from approximately 1 µg of isolated RNA, using 0.5 µg of random examer 
primers (Promega), 100 u of M-MLV reverse transcriptase (NEB), 1 mM dNTPs in the presence of 
40 u of RNasin Plus RNase Inhibitor (Promega). The 1 hour long reaction was conducted at 42°C.  
PCR based on the cDNA template (7 µl) was performed using sbmA-yaiW fw/sbmA-yaiW rev 
primers to amplify the intergenic region between sbmA and yaiW in a reaction mix prepared as 
follows (total volume of 50 µl): 2 mM MgCl2 (Promega), 0.2 mM dNTPs (Euroclone), 0.25 µM 
sbmA-yaiW fw primer, 0.25 µM sbmA-yaiW rev primer, in presence of 2.5 u of Taq polymerase 
(Promega) in Go Taq Buffer (Promega).  
The amplification programme was composed of pre-denaturation (94°C 5 min), 30 amplification 
cycles (94°C 30 sec, 56°C 1 min, 72°C 30 sec) and the final elongation (72°C 7 min). The products 
were separated electrophoretically on a 0.8% agarose gel and visualized on a UV transilluminator.  
 
Solutions and Reagents 
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6 × Loading Buffer: 10 mM Tris-HCl, 60 mM EDTA, 0.03% bromophenol blue, 30% glycerol. 
3.11.2. Cloning of yaiW in the pMAL-c2 plasmid 
 
To move to another expression system, yaiW was cloned EcoRI-BamHI into the pMAL-c2 plasmid. 
A standard PCR reaction was performed to amplify yaiW in a reaction mixture prepared as follows 
(total volume of 50 µl): 1 µg of HB101 gDNA, 0.2 mM dNTPs (Euroclone), 0.25 µM MBP_yaiW 
fw, 0.25 µM MBP_yaiW rev, in presence of 1 u of Vent polymerase (Promega) in Vent Buffer 
(Promega).  
The amplification programme was composed of pre-denaturation (94°C 5 min), 30 amplification 
cycles (94°C 1 min, 59°C 1 min, 72°C 1 min 20 sec) and the final elongation (72°C 5 min). The 
products were separated electrophoretically on a 0.8% agarose gel to check the presence of the 
amplification product and then digested with EcoRI (New England Biolabs) and BamHI (New 
England Biolabs) for 4 hours at 37°C. In parallel the pBlueScript and pMAL-c2 plasmids were 
extracted from E. coli DH5α cells using the EuroGOLD Plasmid Miniprep Kit (Euroclone) and 
submitted to digestion with EcoRI and BamHI. Finally the insert and the plasmids were cleaned up 
using the Illustra Purification Kit (GE Healthcare) and a standard ligation reaction was set up o/n at 
16°C to ligate yaiW in the pBlueScript cloning vector (Table 5). YaiW gene cloned into pBlueScript 
was then submitted to sequence analysis, excised from the vector and ligated EcoRI-BamHI in the 
pMAL-c2 expression plasmid. The reaction mixtures for the ligation of yaiW into pBlueScript and 
pMAL-c2 plasmids are reported in Table 5.  
 
Table 5. List of the reagents and volumes used for the ligation reaction. 
 
 Ligation in pBlueScript Ligation in pMAL-c2 
Plasmid 60 ng 60 ng 
Insert 120 ng 60 ng 
T4 10 × Buffer 1 µl 1 µl 
T4 Ligase 1 µl (2.5 u) 1 µl (2.5 u) 
Water up to 10 µl up to 10 µl 
 
3.11.3. Cloning of yaiW into the pUT18 plasmid 
 
To test the putative interaction between SbmA and YaiW, yaiW was cloned into the pUT18 plasmid 
both with and without the lipobox signature. Since the bacterial two-hybrid system is based on the 
reconstitution of a functional adenylate cyclase mediated by the interaction between the two fusion 
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proteins occurring at the inner membrane or cytoplasmic level, we decided to clone the yaiW gene 
omitting the first 66 bp which correspond to the lipobox signature responsible for the targeting to 
the outer membrane. With this aim a standard PCR reaction was performed to amplify yaiW with 
the yaiW - 66 fw and yaiW rev primers as described in Section 3.11.2. The PCR product was then 
digested with PstI (New England Biolabs) and EcoRI (New England Biolabs) and ligated into the 
pUT18 plasmid. In parallel a second PCR reaction was set up to amplify yaiW with the yaiW fw 
and yaiW rev primers, the PCR product was digested with PstI and EcoRI and ligated into the 
pUT18 plasmid. The two obtained constructs were used together with pKNT25(sbmA) to co-
transform competent BTH101 cells.  
3.11.4. Genomic library construction 
3.11.4.1. Preparation of the cloning vectors 
 
The plasmids pUT18 and pUT18C were extracted from previously transformed E. coli DH5α using 
the EuroGOLD Plasmid Miniprep Kit (Euroclone) and quantified spectrophotometrically. 
Approximately 45 µg of each plasmid were digested with 80 u of BamHI (New England Biolabs) 
for 8 hours at 37°C. The whole digestion mix was then loaded onto a 0.8% agarose gel and 
separated by electrophoresis (3 hours, 50 V), in parallel with a MW marker (SharpMass 1 kb DNA 
ladder, EuroClone). The gel band containing the linearized plasmid was excised and the DNA was 
eluted using the Illustra Purification Kit (GE Healthcare). As the digestion produced blunt ends, the 
linear plasmids were subjected to a three-step dephosphorylation, with 30 u of Calf Intestinal 
Phosphatase (CIP, New England Biolabs) initially added to the reaction mix, 20 u added after 2 
hours at 37°C and additional 10 u added after other 2 hours for another 2 hours of incubation. 
Finally the reaction was stopped by the addiction of EDTA at a final concentration of 50 mM and 
the prepared plasmids were purified using the Quick Clean 5M PCR Purification Kit (GenScript. 
Corp.). 
3.11.4.2. Extraction of genomic DNA from E. coli HB101  
 
Genomic DNA (gDNA) from E. coli HB101 was extracted from an o/n bacterial suspension of 20 
ml. Briefly, the cells were pelleted and resuspended in 2 ml of 1× TE buffer, 2.5 ml of 2% sarkosyl 
in 1× TE and lysed by several freeze-thaw cycles. 10 µl of Rnase A (10 mg/ml, Sigma) were added 
and the sample was incubated at 37°C for 20 minutes. Then 100 µl of Proteinase K (20 mg/ml, 
Sigma) were added and the incubation was continued for another 15 minutes. Afterwards an equal 
volume of phenol/chloroform/isoamyl alcohol mix (25:24:1) was added, mixed thoroughly and 
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centrifuged using a Biofuge Pico microcentrifuge (Heraeus) at 4,000 rpm for 10 min. The upper 
phase was collected and transferred into a new tube, and an equal volume of chloroform was added, 
followed by another centrifugation and transfer of the upper phase into a new tube. Subsequently, a 
solution of 5 M NaCl was added to reach the final concentration of 0.2 M, which was followed by 
the addition of isopropanol (1:1). The precipitated DNA was transferred with a pipette tip into a 
tube containing 70% ethanol and centrifuged (13,000 rpm 5 min). The supernatant was discarded 
and the extracted DNA was dried and resuspended in sterile water. The concentration and purity of 
DNA was estimated spectrophotometrically by measuring the absorbance ratios at 230/260/280 nm. 
 
Solutions and Reagents 
 
1 × TE Buffer: 10 mM Tris-HCl, 1.0 mM EDTA, pH 8.0. 
3.11.4.3. Partial digestion of the genomic DNA 
 
Five restriction enzymes were tested (PstI, SalI, XbaI, EcoRI, Sau3AI) to select the most evenly 
distributed digestion profile of gDNA. The digestions were carried out at 37°C for 6 hours with the 
use of 20 µg of gDNA and 10 u of each enzyme (all from New England Biolabs). Sau3AI was 
selected for further procedures. Approximately 100 µg of gDNA were digested with 50 u of Sau3AI 
in a total reaction volume of 500 µl. Every minute an aliquot of 50 µl of reaction was taken and 
thrown in liquid nitrogen in order to stop immediately the reaction. At the end of the whole 
procedure (10 minutes) the restriction enzyme was inactivated by heating the aliquots at 65°C for 
15 minutes and the samples were loaded onto a 0.8% agarose gel (3 hours, 50 V). The fragments 
obtained after 1 to 5 minutes of digestion were pooled together and submitted to a second round of 
digestion with other 20 u of Sau3AI. In this case aliquots of 50 µl of reaction were taken after 2, 3, 
4, 5 minutes and freezed in liquid nitrogen as described above. The restriction enzyme was 
inactivated by heating the aliquots at 65°C for 15 minutes and the samples were loaded onto a 0.8% 
agarose gel (3 hours, 50 V). This procedure allowed us to obtain two different pools of fragments 
(pool A after the first digestion and pool B corresponding to the fragments submitted to the second 
round of digestion) that were ligated separately into pUT18 and pUT18C plasmids. The ligation 
reaction for each pool of fragments was set up in parallel with an insert-plasmid molar ratio of 2:1 
or 1:1 for both the pUT18 and pUT18C plasmid. Afterwards 3 µl of each ligation mix were used to 
transform E. coli DH5α cells by electroporation and the transformants were plated on LB agar 
plates containing ampicillin so as to allow the growth only of those cells that assumed the plasmid 
containing the gDNA fragment. The colonies obtained from the transformation with fragments of 
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the pool A and the pool B were collected separately for each plasmid and stored at -80°C, thus 
generating a library obtained from the ligation of fragments of the pool A in the pUT18 and in the 
pUT18C plasmids, and a second library obtained from the ligation of fragments of the pool B in the 
pUT18 and pUT18C plasmids. Moreover a third library was obtained by pooling together the 
colonies transformed with genomic fragments of both the pool A and B cloned both in the pUT18 
and pUT18C plasmids. This third library was then selected for the co-transformation together with 
pKNT25(sbmA) into competent E. coli BTH101 cells in order to screen the whole proteome of E. 
coli to look for putative SbmA-interactors. The library dimension was determined by plating serial 
dilutions of the suspension of transformed cells on LB agar plates containing ampicillin, in order to 
obtain a countable amount of colonies. In parallel the plasmids from 40 colonies for each library, 
obtained with the pool A and pool B of genomic fragments, were extracted and the 
presence/absence of insert was checked both by electrophoretic and PCR analysis. The library 
dimension was then calculated with a proportion between the total amount of clones obtained by 
plating the transformants on selective medium and the percentage of clones carrying the plasmid 
with an insert.   
3.11.5. Cloning of fieF into pUT18 plasmid 
 
On the basis of the predicted topology of FieF reported in literature (Daley et al., 2005), the full-
length fieF gene was cloned BamHI-EcoRI into pUT18 plasmid. A standard PCR reaction was 
performed to amplify fieF in a reaction mixture prepared as follows (total volume 100 µl): 800 ng 
of HB101 gDNA, 0.2 mM dNTPs (Euroclone), 0.25 µM fieF fw primer, 0.25 µM fieF rev primer, 
in presence of 2 u of Vent polymerase (Promega) in Vent Buffer (Promega).  
The amplification programme was composed of pre-denaturation (94°C 5 min), 30 amplification 
cycles (94°C 1 min, 59°C 1 min, 72°C 55 sec) and the final elongation (72°C 5 min). The PCR 
product was then loaded onto a 0.8% agarose gel (50 V, 3 hours) and the band was excised using 
the Illustra Purification Kit (GE Healthcare). Both the insert and the pUT18 plasmid, extracted from 
DH5α cells using the EuroGOLD Plasmid Miniprep Kit (Euroclone), were digested in parallel with 
EcoRI (New England Biolabs) and BamHI (New England Biolabs) at 37°C for 4 hours. Afterwards 
both the insert and the plasmid were submitted to the clean up using the Quick Clean 5M PCR 
Purification Kit (GenScript. Corp.) and ligated as follows: 180 ng of pUT18 plasmid with 250 ng of 
insert in presence of 2.5 u of T4 Ligase (Promega) in T4 Ligase Buffer (Promega).  
The reaction was performed o/n at 16°C. The ligation mixture was then used to electroporate DH5α 
cells and the colonies carrying a plasmid with the insert were picked up and used to prepared a 
glycerol stock.  
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3.12. Isothermal Titration Calorimetry (ITC)  
 
ITC measurements were carried out on a MicroCal MCS titration calorimeter (MicroCal, Inc., 
Northampton, MA) at the MPL, Imperial College London. ZnCl2 was dissolved in the same solution 
in which SbmA was purified and the concentration of the stock solution used was 2 mM. The titrant 
and the SbmA sample were throughly degassed before each titration. SbmA samples at a 
concentration ranging from 13 to 123 µM were placed in a 300 µl reaction cell and the reference 
cell was filled with deionized water. All titrations were performed at 25°C. After temperature 
equilibration, successive injections of the titrant were made into the reaction cell in 2.5 µl 
increments at 180 seconds intervals with stirring at 1,000 rpm to ensure a complete equilibration. 
The resulting heats of reaction were measured over 16 consecutive injections. Control experiments 
to determine the heats of titrant dilution were carried out by making identical injections in absence 
of SbmA. The net reaction heat was obtained by subtracting the heat of dilution from the 
corresponding total heat of reaction. The titration data were deconvoluted based on a binding model 
containing one binding site using the MicroCal Origin software.  
3.13. Fluorescence anisotropy measurements 
 
Fluorescence anisotropy measurements were carried out in a SpectraCQ spectrofluorimeter (Horiba, 
FL3-11TAU) at the MPL, Imperial College London. The anisotropy values were determined using 
the following equations:  
r = (IVV – G × IVH)/(IVV + 2G × IVH)   
G = IHV/IHH 
where r is the anisotropy value, IVV and IVH are the emission intensities when the excitation 
polarizer is vertically oriented and the emission polarizer is oriented vertically and horizontally, 
respectively. G is the correction factor. The excitation and emission wavelengths used were 544 nm 
and 570 nm, respectively. All the measurements were performed in a 100 µl cuvette at 20°C 
titrating a solution of Bac7(1-35)-BY TMR C5 0.1 µM in 20 mM Tris-HCl pH 7.5, 150 mM NaCl, 
0.03% n-dodecyl β-D-maltoside (DDM) with increasing amounts of the purified SbmA protein in 
the same buffer.  
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4. RESULTS 
4.1. Characterization of the SbmA transport system in E. coli 
4.1.1. Expression and purification of recombinant SbmA 
 
In a previous work, sbmA has been cloned into the pQE-9 plasmid in fusion with a 6×His tag. We 
expressed and purified the recombinant protein on a Ni-NTA resin (Figure 4.1), in order to use it for 
in vitro studies. Given the highly hydrophobic nature of SbmA, a lot of effort has been put into 
finding the best conditions to express and purify the protein.  
 
 
 
Figure 4.1. Expression and purification of recombinant SbmA. A) Expression of the recombinant protein in E. coli 
XL-1 Blue. Left: Coomassie staining of the soluble fraction of the cell lysate non-induced or induced with 1 µM IPTG. 
Right: Western blot analysis with the anti-His tag antibody of the non-induced and induced cell lysates. B) Silver 
staining of the fractions of the recombinant SbmA obtained  in different elution conditions from the Ni-NTA resin. C) 
Purification of the recombinant protein. Left: Silver staining of the recombinant protein eluted with 100 mM imidazole. 
Right: Western blot analysis with the anti-His tag antibody of the eluted protein. 
4.1.2. In vitro study of the binding of SbmA to its known substrate Bac7 
 
Since the proline-rich peptide Bac7 represents one of the known substrates of SbmA, we first 
studied the binding of Bac7 to the protein, to determine whether it occurs directly and does not 
require a periplasmic substrate-binding protein (PBP). In our laboratory two different fragments of 
the mature peptide are currently used, the fragment corresponding to amino acids 1 to 35, which 
shows an antimicrobial activity comparable to that of the full-length peptide, and the fragment 
corresponding to residues 1 to 16, which still retains a good antimicrobial activity. 
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With the aim of investigating the binding of SbmA to Bac7, we performed an affinity 
chromatography assay immobilizing the fragment of the peptide Bac7(1-35) on the resin and 
passing a purified aliquot of SbmA through the column. We used both the native protein, obtained 
after cleavage of the GFP moiety from the SbmA-GFP fusion protein (kindly provided by Dr. K. 
Beis), and the protein expressed in our laboratory with a 6-His-tag. As shown in Figure 4.2, both 
purified proteins were able to bind directly to Bac7(1-35).  
 
 
 
Figure 4.2. In vitro study of the binding of SbmA to Bac7. A) Affinity chromatography of native and 6-His-tag 
SbmA proteins onto L-Bac7(1-35) resin. As a negative control the binding of the native SbmA protein onto the 
unfunctionalized Cys resin has been evaluated. FT: unbound SbmA. B) Western blot with the anti-SbmA antibody of 
the affinity chromatography of native and 6-His-tagged SbmA proteins onto L-Bac7(1-35) resin. The effect of the 6-
His-tag on the electrophoretic mobility of the protein is detectable as a slight delay in the migration into the SDS-PAGE 
gel.  
 
To confirm these results, we performed fluorescence anisotropy experiments at Imperial College in 
the laboratory of Dr K. Beis. This technique is based on the principle that a small fluorescent 
molecule which is freely tumbling in solution, when excited with polarized light, emits mostly 
depolarized light. On the opposite, when the small fluorescent molecule is bound to a partner 
molecule, the binding decreases the rate of tumbling so that the amount of polarized light emitted 
by the fluorescent molecule increases. The ratio between polarized versus depolarized light is 
measured as the anisotropy value and is proportional to the binding between the two molecules.  
4. Results 
 57 
For this assay a fluorescent derivative of the peptide, Bac7(1-35)-BY, was obtained after 
conjugation of the peptide with the thiol-reactive BODIPY FL dye, which has previously been 
shown not to interphere with the antimicrobial activity of the peptide (data not shown).  
We titrated Bac7(1-35)-BY with increasing concentrations of the purified protein. As shown in 
Figure 4.3, the titration of 0.1 µM Bac7(1-35)-BY with increasing concentrations of SbmA 
produces a significant increase in the anisotropy value, thus indicating that the protein is binding to 
the peptide. Moreover, the binding curve reaches a plateau around 1 µM SbmA suggesting that the 
protein becomes saturated. Taken together these results indicate that the binding of Bac7 to SbmA 
occurs directly, without the requirement of a SBP. 
 
 
 
Figure 4.3. Fluorescence anisotropy of the binding of Bac7 to SbmA. A solution of 0.1 µM Bac7(1-35)-BY in 20 
mM Tris-HCl pH 7.5, 150 mM NaCl, 0.03% n-dodecyl β-D-maltoside (DDM) has been titrated with increasing 
concentrations of purified SbmA protein in the same buffer solution.  
 
Since some detergents may interphere with the measurement of the anisotropy value, a titration of 
the fluorescent peptide with only the buffer was performed in order to evaluate the background of 
the experiment. The titration of the peptide with the buffer did not produce a significant increase in 
the anisotropy value (data not shown).  
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4.1.3. SbmA is able to dimerize both in vitro and in vivo 
 
To study whether SbmA can form dimers as several TMDs of ABC transporters, we performed in 
vitro cross-linking experiments with the purified protein. As shown in Figure 4.4A, SbmA was able 
to dimerize in the presence of 0.25% glutaraldehyde. 
To confirm this result, we took advantage of the bacterial two-hybrid system. Based on the 
interaction-mediated reconstitution of a functional adenylate cyclase (Karimova et al., 1998), this 
system allowed us to verify if SbmA forms dimers also in vivo. Dimerization of SbmA resulted in 
functional complementation between T18 and T25 subunits of the adenylate cyclase and, therefore, 
cAMP synthesis. Cyclic AMP in turn regulates the expression of lacZ, and therefore bacteria 
become able to utilize lactose as a carbon source, determining a high β-galactosidase activity 
detectable on x-Gal/IPTG agar plates.  
The two plasmids encoding SbmA fused to the N-terminus of the two different subunits of the 
adenylate cyclase has been kindly provided by Dr G. C. Walker and the cloning strategy was 
consistent with the predicted topology for SbmA, suggesting a cytoplasmic localization of the C-
terminus. This observation is in agreement with the results of a global topology study performed on 
membrane proteins of E. coli (Daley et al., 2005). 
In this way we were able to demonstrate that SbmA is able to dimerize (Figure 4.4B), thus 
confirming the results obtained by the cross-linking assay and indicating that this is likely the active 
form of the protein. Moreover, we also measured the strength of the interaction between the two 
monomers as β-galactosidase activity in Miller units (Figure 4.4C) and we obtained a level of 
interaction comparable to that of the positive control.  
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Figure 4.4. In vitro and in vivo dimerization of SbmA. A) Western blot of the SbmA cross-linking assay. In absence 
of glutaraldehyde, SbmA is present only in its monomeric form, while adding increasing amounts of glutaraldehyde 
there is an increase in the dimeric form of SbmA. At high percentage of cross-linking agent (0.5 %) superaggregated 
forms of the protein become visible. B) Bacterial two-hybrid assay. Left: cotransformation with pUT18C-zip and 
pKT25-zip vectors (positive control). Middle: cotransformation with pKNT25-sbma and empty pUT18. Right: 
cotransformation with pUT18-sbma and pKNT25-sbma. C) β-galactosidase assay to quantify the strength of interaction 
of the SbmA-SbmA dimer. β-galactosidase activity is measured as Miller Units (M.U.). Results are the mean of more 
than three independent experiments.  
4.1.4. The SbmA-mediated transport of Bac7 is proton- rather than ATP-driven 
 
To determine the driving force of the transport, we measured the uptake of Bac7(1-35)-BY in 
presence of 2,4-dinitrophenol (DNP) and/or sodium arsenate. DNP is a ionophore that has a direct 
effect on the proton gradient, moving protons across the inner membrane thus affecting both the pH 
and the membrane potential. On the other hand, the sodium arsenate inhibits directly the production 
of ATP via substrate-level phosphorylation (Cascales et al., 2000; White 2006).  
To correlate the uptake of Bac7(1-35)-BY with the ATP content of the cells, we measured the ATP 
level in the bacterial cells treated with DNP, sodium arsenate or both of them. Both the uptake assay 
and the measurement of the ATP content have been performed in parallel in the E. coli wild type 
strain BW25113 and in the isogenic mutant strain JW3710, which has a deletion in the gene atpD 
encoding the β subunit of the ATP synthase and thus is impaired in ATP synthesis. 
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The ATP content of E. coli BW25113 collapsed after treatment with the sodium arsenate, but the 
uptake of Bac7(1-35)-BY still remained high. On the contrary, after treatment with the DNP the 
uptake was dramatically reduced even if the content of ATP in the bacterial cells was not critically 
low (Figure 4.5A-B). Also the JW3710 strain showed a significant decrease in the uptake of 
Bac7(1-35)-BY after treatment with the DNP which seems to be independent from the ATP content, 
while the uptake in presence of sodium arsenate remained comparable to that of the untreated 
sample (Figure 4.5C-D). Intriguingly the amount of peptide internalized by the E. coli wild-type 
and the AtpD-deficient strain was approximately the same, thus suggesting that the ATP production 
via the ATP synthase is not essential for the uptake of Bac7. Moreover, the treatment of the 
bacterial cells with both the DNP and the sodium arsenate produced  in both the strains a decrease 
in the uptake which was comparable to that of the DNP, thus highlighting the predominant effect of 
the uncoupler on the uptake and confirming that this effect is not directly related to the ATP 
content.  
These results show that the ATP level in the cells is not a critical factor for the uptake, while the 
presence of a proton gradient seems to play an important role, since its disruption reduces the 
amount of the peptide that is internalized.  
 
 
 
Figure 4.5. Effects of different inhibitors on the uptake of Bac7(1-35) and the ATP content of the cells. A) Uptake 
of Bac7(1-35)-BY in E. coli BW25113 cells measured as medium fluorescence intensity (M.F.I.). Bacterial cells (1 × 
10-6 cfu ml-1) were incubated in MH Broth with 0.25 µM Bac7(1-35)-BY alone, in presence of 5 mM sodium arsenate 
(ARS), 5 mM DNP or both of them for 10 min at 37°C, washed three times with buffered high-salt solution and the 
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fluorescence intensity measured by flow cytometry. * p < 0.03 versus CTRL, ** p < 0.001 versus CTRL (Student-
Newman-Keuls Multiple Comparisons Test, ANOVA). B) ATP content of  E. coli BW25113 cells measured as 
luminescence produced by the firefly luciferase reaction. The level of luminescence is expressed as a percentage of 
luminescence after treatment with the different compounds with respect to the control, which represents the 100%.  C) 
Uptake of Bac7(1-35)-BY in E. coli JW3710 (∆atpD) cells measured as medium fluorescence intensity (M.F.I.). * p < 
0.03 versus CTRL (Student-Newman-Keuls Multiple Comparisons Test, ANOVA). D) ATP content of  E. coli JW3710 
(∆atpD) cells measured as luminescence produced by the firefly luciferase reaction. §§ p < 0.005 versus ARS (Student-
Newman-Keuls Multiple Comparisons Test, ANOVA).  
4.1.5. Search for other components of the transport system 
4.1.5.1. SbmA and yaiW genes form a transcriptional unit, but the two proteins don’t seem  to 
interact with each other 
 
Since the different subunits of most ABC transporters are clustered in the same operon, with the 
aim of finding the other components of the SbmA transport system, we analyzed the sbmA locus 
and we found that downstream to sbmA gene lies yaiW (with a space of only 13 nucleotides), a gene 
with unknown function. To investigate whether the proteins encoded by these two genes may be 
functionally linked, we checked at first whether the two genes are co-expressed.  
Total RNA was extracted from E. coli HB101, retrotranscribed and cDNA submitted to PCR 
amplification with a forward primer specific for the 3’-terminal end of sbmA and a reverse primer 
matching the 5’-terminal end of yaiW, in order to amplify the intergenic region between sbmA and 
yaiW (Figure 4.6). The amplification gave a product of the expected size, thus demonstrating that 
they may be transcribed into a unique mRNA (Figure 4.6). 
 
 
 
Figure 4.6. RT-PCR of the intergenic region between sbmA and yaiW.  Amplicons obtained by using genomic DNA 
(positive control, lane 2) or cDNA (lane 3) as templates have been shown. Lane 1: negative control. 
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To evaluate a possible in vitro interaction between SbmA and YaiW, we expressed and purified this 
protein. Initially we cloned yaiW into the pQE-9 plasmid, which has a 6xHis purification tag, but 
unfortunately this first attempt was not successful. YaiW was almost totally detected in the 
insoluble fraction of a protein lysate. We changed the expression conditions, however most protein 
was found in the pellet (Figure 4.7A). To overcome this problem, we moved to another expression 
system, cloning yaiW into the pMALc2 plasmid. YaiW was cloned downstream of the maltose-
binding protein (MBP) allowing a better solubilization of the protein and its purification on 
amylose-resin. Although the soluble percentage of the protein wasn’t as high as expected, it was 
sufficient to purify it (Figure 4.7B-C).  
 
 
 
Figure 4.7. Expression and purification of YaiW. A) Expression of YaiW into pQE-9 plasmid. Lanes 1, 2: non 
induced and induced total cell lysate; lanes 3, 4: soluble and non soluble fraction of induced cell lysate. YaiW 
expression in the soluble and non soluble fraction was also detected by Western blotting with anti-His tag antibodies. B) 
Expression of YaiW into pMAL-c2 vector. Lanes 1, 2: non induced and induced total cell lysate; lanes 3, 4: soluble and 
non soluble fraction of induced cell lysate. C) Purification of the fusion protein MBP-YaiW on amylose resin. Lane 1: 
eluted with Sample Buffer; lanes 2-8: fractions collected after elution with maltose. 
 
We took advantage of the fusion with MBP to bind YaiW to an amylose-resin to perform some 
affinity chromatography assays with purified SbmA both in the monomeric (Figure 4.8A) and 
cross-linked dimeric form (Figure 4.8B).  
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Figure 4.8. In vitro and in vivo study of the putative interaction between SbmA and YaiW. A) Western blot 
analysis of the purified 6-His-tagged SbmA after affinity chromatography assay on YaiW-linked resin. Lane 1: control 
SbmA; lane 2: SbmA bound to the YaiW-resin; lane 3: SbmA bound to the unfunctionalized amylose-resin; lanes 4,5: 
flow-through of sample loaded onto YaiW- and unfunctionalized resins. B) Western blot analysis of the purified SbmA 
after cross-linking with 0.25 % glutaraldehyde and affinity chromatography assay on YaiW-linked resin. Lanes 1,2: 
SbmA bound to the YaiW- and unfunctionalized resins; lanes 3,4: flow-through of sample loaded onto YaiW- and 
unfunctionalized resins. C) Bacterial two-hybrid assay. 1: cotransformation with pUT18C-zip and pKT25-zip vectors. 2: 
cotransformation with pKNT25-sbma and pUT18. 3: cotransformation with pUT18-yaiW(-66) and pKNT25-sbma. 
 
Unexpectedly, it was found that SbmA strongly bound to the amylose resin making complicated the 
analysis (Figure 4.8A-B). However, immobilized YaiW did not increase the amount of the retained 
SbmA indicating that, at least in this condition, there was not any direct interaction between the two 
proteins. 
We then also tried to detect an interaction using the bacterial two-hybrid system. YaiW is predicted 
to be a lipoprotein showing the typical signature sequence of lipoproteins targeted to the outer 
membrane (lipobox) and this is likely the reason why it was so poorly soluble in our expression 
attempts. By using both the truncated, which corresponds to the YaiW-T18 fusion without the 
lipobox signature (Figure 4.8C), or full-length YaiW (data not shown), no detectable interaction 
between the two proteins has been revealed thus leaving unknown the role of YaiW in relationship 
to SbmA. However, given the technical challenges of the in vitro experiments and the constraint 
that the adenylate cyclase halves both need to be in the cytoplasm in the two-hybrid experiments, it 
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remains formally possible that YaiW could interact with the periplasmic face of SbmA and have a 
role in the mechanism of action of Bac7.  
In order to investigate whether also YaiW may have a role in Bac7 resistance, we evaluated the 
growth kinetics of a ∆yaiW strain in presence of sublethal concentrations of both Bac7(1-16) 
(Figure 4.9) and Bac7(1-35) (data not shown).  
 
 
 
Figure 4.9. Growth kinetics of E. coli BW25113, ∆sbmA and ∆yaiW strains in MH Broth with Bac7(1-16). A) 
Growth kinetics in MH Broth. Bacterial suspensions of 1 × 106 cells/ml have been grown in MH Broth without the 
peptide for 4 hours and the OD at 620 nm has been measured every 10 minutes. B) Growth kinetics in MH Broth in 
presence of 0.25 µM Bac7(1-16). 
 
In both cases the ∆yaiW strain shows a decreased susceptibility to the peptide, even if lower than 
that observed in the ∆sbmA strain, thus leading us to hypothesize that these two proteins may share 
a common function in the resistance to Bac7. To confirm this hypothesis we measured the uptake of 
Bac7(1-35)-BY both in the ∆sbmA and ∆yaiW strains (Figure 4.10).  
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Figure 4.10. Uptake of Bac7(1-35)-BY in ∆sbmA and ∆yaiW E. coli strains. Medium fluorescence intensity (M.F.I.) 
of BW25113, BW25113 ∆sbmA and ∆yaiW strains exposed to Bac7(1-35)-BY for 10 or 60 min. Results are the mean 
of two independent experiments. 
 
Preliminary data (only two experiments) indicated that the ∆yaiW strain has a decreased level of 
internalization of the peptide and are in agreement with the results obtained in the growth kinetics 
assay. 
4.1.5.2. Bacterial two-hybrid experiments identified potential SbmA-interacting proteins 
 
With the aim of identifying SbmA interacting partners, and in particular of searching for the 
putative NBD subunit, we screened the whole proteome of E. coli (prey) against SbmA (bait).  
The genomic DNA of E. coli HB101 has been extracted and partially digested with Sau3AI (Figure 
4.11).  
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Figure 4.11. Partial digestion of the genomic DNA extracted from E. coli HB101. The extracted DNA has been 
submitted to a first round of digestion and the fragments obtained after 1 to 5 minutes from the first digestion were 
pooled and submitted to a second round of digestion.  
 
The obtained genomic fragments were inserted in parallel both at the 3’- end and 5’- end of the T18 
subunit, thus generating two libraries differing in the prey’s orientation with respect to T18. This 
strategy allowed us to enhance the probability to obtain functional fusions. After the cloning 
procedure, DH5α cells have been transformed with the ligation of each library and the plasmids 
extracted from 40 colonies per each have been analyzed by both electrophoresis and PCR. From this 
screening, the 60 % of the tested plasmids carried an insert and the length of the inserted fragments 
varied from 0.35 to 4.5 kb, with a length of 1.3 kb on average. The size of each library was 
approximately 3.5 × 104 clones, enough to obtain a sufficient coverage of the E. coli genome.  
This library and the sbmA gene were introduced by cotransformation into E. coli BTH101 cells, an 
adenylate cyclase-deficient strain, and the cotransformants were then plated onto LB x-Gal/IPTG 
agar plates to select positive clones.  
From a screen of ~1.2 × 104 transformants, 55 colonies were considered positives for the activation 
of the lacZ reporter gene. To test the strength of interaction with SbmA, all these 55 colonies were 
submitted to a β-galactosidase activity assay in vitro (data not shown) and 23 clones showing the 
highest activities were selected and their inserts sequenced. Twenty clones carried genes fused in-
frame with the ORF encoding T18, two carried genes that were reverse inserted and one a gene that 
was out of frame. Among the 20 clones carrying genes fused in-frame with the ORF encoding T18, 
some of them carried the same library fragment, thus reducing the total number of putative SbmA 
partners to 9 (Table 1): an inner membrane protein  (FieF), a putative outer membrane protein 
(YdbA2), six cytoplasmic proteins (YajD, BipA, Add, LysU, Rmf, ClpB) and YcfD, whose 
localization and function are yet unknown. Among these proteins no specific proteins with a 
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nucleotide-binding domain (NBD) were identified, a result in agreement with our experiments 
indicating that the proton gradient rather than the ATP hydrolysis seems to play an important role in 
the transport of the substrate. Furthermore, we did not find, among the putative interactors, SbmA 
itself and this may be due to the library dimension, which does not have a 100% coverage of the E. 
coli genome, or to cloning problems. With respect to the latter hypothesis, the sbmA gene does not 
show any recognition site for Sau3AI, therefore it could happen that the gene was part of a bigger 
genomic fragment difficult to be cloned into the vector.  
 
Table 1. List of the potential SbmA-interacting proteins identified via bacterial two-hybrid. 
 
Gene 
name 
Fragment dimension 
Product 
localization 
Function 
Number of 
clones 
References 
fieF 622 out of 903 bp IM Zn, Fe, Cd efflux 
 
3 
Chao and Fu, 2004; 
Grass et al., 2005; Lu 
and Fu, 2007 
ydbA2 787 out of 3324 bp OM 
Unknown 
 
3 
Fernandez De 
Henestrosa et al., 2000; 
Salmon et al., 2005 
yajD 241 out of 348 bp Cytoplasm Unknown 1 Gardel et al., 1990 
bipA 799 out of 1824 bp Cytoplasm 
Ribosome-binding 
GTPase 
1 
deLivron and Robinson, 
2008; Farris et al., 
1998; Grant et al., 2003 
add 166 out of 1002 bp Cytoplasm 
Adenosine 
deaminase 
2 Nygaard, 1978 
lysU 352 out of 1518 bp Cytoplasm 
Lysyl-tRNA 
synthetase 
2 
Clark and Neidhardt, 
1990; Desogus et al., 
2000 
ycfD 475 out of 1122 bp Unknown Unknown 6 Serres et al., 2001 
rmf 22 out of 168 bp Cytoplasm Ribosome-
modulating factor 
1 
Aiso et al., 2005; 
Apirakaramwong et al., 
1998  
clpB 259 out of 2574 bp Cytoplasm Chaperone 1 
Akoev et al., 2004; 
Barnett et al., 2000; 
Ben-Zvi and 
Goloubinoff, 2001 
 
Figure 4.12 shows the strength of the interaction measured as β-galactosidase activity for the 9 
different clones carrying a library fragment fused in frame to the ORF of T18.  
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Figure 4.12. β-galactosidase assay to quantify the strength of interaction with SbmA.  Each bar represents the 
enzymatic activity due to interaction between SbmA and the different fragments of the library. In the case of the same 
gene present in more than one clone (e. g. fieF, ydbA2, add, lysU, ycfD), the interaction of only one representative clone 
has been reported. β-galactosidase activity is measured as Miller Units (M.U.). Results are the mean of three 
independent experiments.  
4.1.5.3. The inner membrane protein FieF  interacts with SbmA 
 
On the basis of the results of the β-galactosidase activity assay, FieF seemed to be the most 
promising interactor of SbmA and thus we focused our attention on this protein, which is involved 
in the efflux of zinc ions from the bacterial cell. The library fragment encoding fieF comprised the 
endogenous promoter and the first 622 bp of the ORF, which was more than a half of the whole 
sequence (which has a total length of 903 bp). To confirm the binding, we tested the interaction 
between SbmA and the FieF full-length. On the basis of the published data about the topology of 
FieF (Daley et al., 2005), we expressed the protein fused N-terminally to the T18 subunit, allowing 
T18 to be located in the cytoplasm (Figure 4.13A). As showed in Figure 4.13B, the level of  β-
galactosidase activity derived from the interaction between SbmA and FieF full-length is 
significantly high, thus confirming the preliminary data obtained with the library fragment. 
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Figure 4.13. A) The proposed topology of the FieF-T18 fusion on the basis of the work of Daley et al., 2005 and a 
proposed topology of the SbmA-T25 fusion based on a comparative analysis using 5 different software (DAS, 
HMMTOP, SOSUI, TMHMM, TMPRED). B) Bacterial two-hybrid assay. Left: cotransformation with pUT18C-zip and 
pKT25-zip vectors (positive control). Middle: cotransformation with pUT18-fieF and pKNT25 (negative control). 
Right: cotransformation with pUT18-fieF (full length) and pKNT25-sbma. C) β-galactosidase assay to verify the 
interaction between FieF and SbmA. β-galactosidase activity is measured as Miller Units (M.U.) in the strain 
cotransformed with pUT18C-zip and pKT25-zip vectors (K+), pUT18-fieF and pKNT25 (K-), pUT18-fieF and 
pKNT25-sbma for the library fragment and full lenght fieF, respectively. Results are the mean of three independent 
experiments. 
4.2. Analysis of the SbmA-FieF interaction with respect to the transport of Bac7  
4.2.1. FieF deletion mutant shows a phenotype similar to, but not as severe as, a ∆sbmA strain 
 
To assess whether FieF is involved in the transport together with SbmA, we measured the 
internalization level of Bac7(1-35)-BY in a ∆fieF strain. When bacteria were exposed to sub-lethal 
concentrations of Bac7(1-35)-BY (Mattiuzzo et al., 2007) a modest (~20%) decrease in the uptake 
of the peptide was observed in the ∆fieF strain compared to the parental wild type strain (Figure 
4.14A).  
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Figure 4.14. Uptake of Bac7(1-35)-BY in the ∆fieF strain and in the fieF complemented strain, in presence (A) 
and absence (B) of sbmA. A) Medium fluorescence intensity (M.F.I.) of BW25113, BW25113 ∆fieF, BW25113 ∆fieF 
+ [pUT18(fieF)] and BW25113 ∆fieF + [pUT18] cells exposed to Bac7(1-35)-BY for 10 min. Results are the mean of 
11 independent experiments. B) MFI of BW25113 ∆sbmA, BW25113 ∆sbmA + [pUT18(fieF)] and BW25113 ∆sbmA + 
[pUT18] cells exposed to Bac7(1-35)-BY for 10 min. Results are the mean of three independent experiments. * p < 0.03 
versus both the wild-type and the ∆fieF strain (Student-Newman-Keuls Multiple Comparisons Test, ANOVA).  
 
When the mutation was complemented, the level of fluorescence increased significantly with 
respect to the wild type strain (~25%). This result  may be due to the high copy number of the 
plasmid used to express fieF in trans. 
Introducing a copy of fieF in trans on a plasmid in the ∆sbmA mutant the level of peptide-derived 
fluorescence did not change (Figure 4.14B). This observation indicates that the increase in Bac7(1-
35)-BY uptake after complementation is strictly dependent on SbmA.  
Taken together these results support the interaction observed in the bacterial two-hybrid 
experiments and strongly suggest that FieF is involved in the SbmA-mediated uptake of Bac7. 
Therefore a common function for the two proteins in the same cellular pathway may be postulated.  
4.2.2. SbmA expression is zinc-dependent and mediated by two distinct mechanisms 
 
As many others metal ions-efflux systems, the expression level of fieF is regulated by intracellular 
metal concentration (Grass et al., 2001). As the zinc concentration increases, the expression of fieF 
raises rapidly to maintain zinc homeostasis. To further investigate the interaction occurring between 
two proteins apparently so different, we decided to test whether zinc ions have an effect also on 
sbmA expression both at the transcriptional and translational level.  
With this aim, we took advantage of the E. coli NC122 strain, which carries the chromosomal 
transcriptional fusion ∆sbmA::lacZY and thus allowed us to measure the level of zinc-mediated 
induction on the endogenous promoter of sbmA.  
Interestingly, we found that ZnCl2 induced sbmA transcription in a concentration-dependent 
manner, with a maximum increase (3 folds) after 30 minutes of incubation with 1 mM ZnCl2 and a 
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rapid decrease at the highest concentration that may be used without causing the death of the cells 
(Figure 4.15A). Moreover, these data correlate with those obtained at the translational level (Figure 
4.15B), showing a remarkable increase in the expression at 0.25 mM ZnCl2 with a maximum 
increase at 1 mM. 
Since sbmA gene is known to be a member of the RpoE regulon (Rhodius et al., 2006), we first 
asked if the effect of zinc ions on sbmA transcriptional level was mediated by rpoE. Therefore, we 
tested the zinc-dependent transcriptional activation of the chromosomal fusion ∆sbmA::lacZY also 
in the rpoE- background (E. coli NC322 strain). Surprisingly, we observed a different induction 
profile, characterized by an increase in sbmA transcriptional level to a maximum of almost 2 folds 
at 1.25 mM ZnCl2, that corresponds to the more toxic concentration at which bacteria are still able 
to grow
 
(Figure 4.15C). As for the NC122 strain, we confirmed these data also by Western blot 
analysis of the endogenous protein (Figure 4.15D).  
 
 
 
Figure 4.15. Effect of increasing concentrations of ZnCl2 on the transcriptional activity of SbmA. A) and C) Zinc-
dependent transcriptional activation of sbmA promoter in the NC122 strain (rpoE+) (A) and NC322 strain (rpoE-) (C) 
measured as β-galactosidase activity in Miller Units (M.U.) in bacteria on exponential phase. Results are the mean of 
four independent experiments. B) and D) SbmA expression levels in the rpoE+ (B) and rpoE- background (D) upon 
treatment of bacterial suspensions with increasing concentrations of ZnCl2. Representative results of three independent 
experiments are shown. The GyraseA (GyrA) was used as internal standard.  
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Taken together these data indicate that SbmA expression is induced by increasing concentrations of 
zinc and that this effect is mostly, but not completely, mediated by RpoE. Indeed we showed that, 
when RpoE is absent, a secondary mechanism is still present in the regulation of SbmA expression.  
To further investigate this second mechanism of regulation, we checked the effect of zinc on SbmA 
expression on stationary-phase rather than exponential-phase bacteria.  
The level of expression was higher in stationary-phase cells, in agreement with Corbalàn (Corbalàn 
et al., 2010), but interestingly the transcriptional profile of sbmA in the rpoE+ background remains 
similar to that obtained for the cells grown until exponential phase (Figure 4.16A). On the contrary, 
in the rpoE- background the level of expression did not increase at any of the zinc concentrations 
tested (Figure 4.16B), thus suggesting that the mechanism by which bacteria induce sbmA 
expression in absence of rpoE is active only during exponential phase.  
 
 
 
Figure 4.16. Effect of increasing concentrations of ZnCl2 on the transcriptional activity of sbmA during 
stationary phase. A) Activity of the sbmA promoter measured as β-galactosidase activity in Miller Units (M.U.) in the 
NC122 strain (rpoE+). B) Activity of the sbmA promoter measured as β-galactosidase activity in Miller Units (M.U.) in 
the NC322 strain (rpoE-). Results are the mean of more than three independent experiments.  
4.2.3. The zinc-mediated increase in SbmA expression correlates with an increased Bac7 uptake and 
peptide susceptibility 
 
Increased expression levels of SbmA should promote an increased uptake of Bac7 and a parallel 
increased susceptibility of E. coli cells. To verify this hypothesis, we measured by flow-cytometry 
the uptake of Bac7(1-35)-BY in wild type BW25113 cells treated with 1 mM ZnCl2. We found that 
the cells showed a significant increase in the amount of internalized peptide with respect to the 
untreated strain (Figure 4.17). Moreover, this increase was completely SbmA-dependent, since the 
treatment of a ∆sbmA strain with ZnCl2 did not have any effect on the uptake of the fluorescent 
peptide.  
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Figure 4.17. Uptake of Bac7(1-35)-BY in E. coli BW25113 and ∆sbmA strains after treatment with 1 mM ZnCl2 
during the growth. To measure the uptake of peptide, BW25113 and ∆sbmA cells were treated with 0.25 µM Bac7(1-
35)-BY for 10 min. Results are the mean of three independent experiments. * p < 0.04 versus n/i (Student-Newman-
Keuls Multiple Comparisons Test, ANOVA).  
 
Furthermore, BW25113 cells treated 1 hour with 1 mM ZnCl2 before the addition of the Bac7(1-35) 
showed a significant increase in the susceptibility to the peptide (Figure 4.18A), and this effect is 
clearly SbmA-dependent, since in the ∆sbmA strain the pretreatment with 1 mM ZnCl2 did not have 
any effect on the susceptibility of the strain to the peptide (Figure 4.18B).  
 
 
 
Figure 4.18. Growth kinetics of E. coli BW25113 and ∆sbmA in MH Broth with Bac7(1-16). Growth kinetics of E. 
coli BW25113 (A) or E. coli ∆sbmA (B) in MH Broth alone (blue curve) or with Bac7(1-16) 0.5 µM (green curve), after 
preincubation with 1 mM ZnCl2 in MH Broth alone (pink curve) or with Bac7(1-16) 0.5 µM (red curve).  
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4.2.4. SbmA is able to bind Zn(II) ions with low affinity 
 
To further investigate the possible role of SbmA in zinc homeostasis, we tested by using isothermal 
titration calorimetry (ITC), at the Oxford University in collaboration with Dr K. Beis, whether this 
protein is able to directly bind zinc ions. The energetic of Zn(II) binding to the purified SbmA was 
examined directly by ITC at 25°C, pH 7.0. An example of heat changes accompanying the binding 
of incremental additions of Zn(II) to SbmA are shown in Figure 4.19. Plots of the integrated heat 
per mole of Zn(II) as a function of the molar ratio of Zn(II) to SbmA are displayed in the lower 
panel. As shown in the upper panel, Zn(II) titration produces a heat exchange corresponding to an 
exothermic reaction. The Zn(II) binding isotherm was fitted to a binding model containing one 
binding site, with ∆H, Ka and binding stoichiometry n values permitted to float.  
 
 
 
Figure 4.19. ITC analysis of zinc binding to SbmA. The upper panel shows the calorimetric titration with 2.5 µl 
injections of 2 mM ZnCl2 into 20 µM SbmA in a 0.3 ml reaction cell containing 20 mM Tris, pH 7.0, 150 mM NaCl, 
0.03% n-dodecyl beta-D-maltoside (DDM).  
 
The fit to this binding model yielded 1.32 equivalents of Zn(II) bound to the site with a Ka value of 
60 µM. The calculated affinity constant indicates that SbmA is able to bind Zn(II) ions with an 
intermediate level of affinity with respect to the two independent binding sites for Zn(II) of FieF, 
which show a calculated Ka of 0.33 µM and 6.3 mM respectively (Chao and Fu, 2004).  
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Given that SbmA, as previously showed, forms dimers in the bacterial inner membrane, we checked 
whether the binding of Zn(II) to SbmA could interphere with its ability to dimerize in vivo. With 
this aim, we assayed the strength of interaction between the two monomers in presence and absence 
of ZnCl2 by measuring the β-galactosidase activity in the bacterial two-hybrid system after the 
addition of 1 mM ZnCl2 to the cells. As shown in Figure 4.20, Zn(II) did not have a significant 
effect on the dimerization of SbmA.  
 
 
 
Figure 4.20. β-galactosidase assay to measure the strength of the interaction between the two SbmA monomers 
both in absence and presence of 1 mM ZnCl2. β-galactosidase activity is measured as Miller Units (M.U.). Results 
are the mean of three independent experiments. 
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5. DISCUSSION 
A number of evidences have stressed the importance of the E. coli inner membrane protein SbmA 
in the bacterial susceptibility to some antibiotics and antibacterial peptides, but the details of its 
function and the characterization of its activity remained elusive until few years ago. A role for 
SbmA in the uptake of proline-rich peptides has only recently been proposed (Mattiuzzo et al., 
2007) and new insights in its function come from the observation that BacA, the SbmA homolog in 
Sinorhizobium meliloti, is essential for the survival of the bacteria into the plant symbiosome and 
the resistance to the nodule-specific cysteine-rich (NCR) peptides released by the plant (Haag et al., 
2011b).  
In this study, we obtained some new insights into the structural organization and function of this 
protein in Gram negative bacteria. SbmA has been predicted to be the transmembrane domain of an 
ABC transporter. In the present work we tryed to establish whether SbmA is part of such a transport 
system and how it works.  
Starting from the observation that many ABC uptake system have a substrate-binding protein 
essential to bind and deliver the substrate to the two transmembrane domains, we investigated the 
binding properties of SbmA with respect to Bac7. Affinity chromatography and fluorescence 
anisotropy assays clearly indicated that SbmA is able to directly bind the peptide, also without the 
requirement of a specific SBP. Since SbmA is also involved in the uptake and the sensitivity of 
quite structurally unrelated molecules, such as microcins, bleomycin and the cysteine-rich nodule-
specific peptides, a low-selective binding may be at the basis of this recognition.  
Other examples of peptide transporters showing a broad substrate specificity are known. The L. 
lactis Opp has the capacity to bind peptides from 5 up to 35 residues and its homolog in S. 
thyphimurium transports peptides from 2 to 5 amino acids with little regard to the sequence 
(Charbonnel et al., 2003). 
By in vitro crosslinking assays and by using a bacterial two-hybrid system we showed that SbmA is 
able to dimerize both in vitro and in vivo, thus indicating that also SbmA, as canonical ABC 
systems, forms homodimers in the bacterial membrane. In addition, other than verifying the ability 
of the protein to dimerize, we also confirmed the cytoplasmic localization of its C-terminus. Indeed, 
only a reconstitution of the two subunits of the adenylate cyclase on the cytoplasmic side of the 
bacterial membrane produces a detectable signal. This result is in agreement with the prediction 
studies of the protein topology indicating that SbmA forms eight transmembrane helices with both 
the N- and C-terminus on the cytoplasmic side and also in agreement with the results of a study on 
the global topology of the E. coli inner membrane proteome (Daley et al., 2005).  
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The most intriguing result, however, is the observation that the uptake of Bac7, to be fully 
accomplished, requires the presence of an electrochemical proton gradient rather than the ATP 
hydrolysis. A major reduction of the uptake of Bac7 could be obtained after the treatment of the 
bacterial cells with the 2,4-dinitrophenol (DNP), an uncoupler molecule which dissipates both the 
electrical and chemical components of the proton motive force, binding protons and ferrying them 
across the inner membrane. This result is also supported by the fact that the screening of the E. coli 
proteome by the two-hybrid assay failed to identify any protein able to bind SbmA with the 
properties typical of a nucleotide-binding domain.  
Interestingly, some cases of ABC transporters energized by a mechanism alternative to ATP 
hydrolysis have already been reported in literature. The drug transporter LmrA of Lactococcus 
lactis is able to act as a secondary-active multidrug uptake system without the requirement of ATP 
when deprived of its NBDs, although it normally has an ATP-binding domain to enable primary-
active multidrug efflux (Venter et al., 2003). These findings suggest that the evolutionary precursor 
of LmrA was a secondary-active substrate translocator that acquired a NBD to become a multidrug 
efflux system.  
It may be that a reverse process might be happened for SbmA, thus leading the protein to switch 
during evolution from ATP hydrolysis to the proton electrochemical gradient as a source of energy 
for the transport.  
Usually the different components of the ABC transporters are encoded as an operon, by genes 
clustered under the control of the same promoter. Looking at the sbmA locus in the E. coli genome, 
we found that downstream to sbmA lies only yaiW, a gene with unknown function and homology 
with none of other components of an ABC system. However, we showed that yaiW is part of the 
same transcriptional unit of sbmA and that these two genes are cotranscribed in a unique transcript.   
YaiW is predicted to be a lipoprotein and shows the typical signature sequence (LAGCSS lipobox) 
that target it to the outer membrane, making it a non-conventional candidate for bacterial two-
hybrid experiments. Despite our efforts, no interaction between YaiW and SbmA was detected in 
vivo by the bacterial two-hybrid system, neither omitting the sequence corresponding to the lipobox 
signature in yaiW, nor in vitro by affinity chromatography assays.  
However, as showed by bacterial growth kinetics and uptake assays the ∆yaiW strain shows a 
phenotype with decreased susceptibility to Bac7. This result supports the hypothesis that YaiW may 
have a role together with SbmA in the transport of Bac7 or other substrates in a manner that does 
not require a physical interaction between the two proteins. On the other hand, given the technical 
challenges of the in vitro experiments and the constraint of the cytoplasmic or inner membrane 
localization of the two adenylate cyclase halves in the bacterial two-hybrid assays, it remains 
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possible that YaiW may interact with SbmA in the periplasmic space and might have an accessory 
role in the transport of the peptide.  
To identify other putative SbmA-interacting partners, we adopted a proteomic approach to screen 
the E. coli proteome via a bacterial two-hybrid system.  
By using this technique we fished out nine potential SbmA interactors and, among them, FieF was 
the only transmembrane protein found. One of the disadvantages of the bacterial two-hybrid system  
based on the reconstitution of the adenylate cyclase is the amount of false-positives due to 
interactions occurring at the inner membrane level (Karimova et al., 1998). As we obtained the 
majority of interactors being located at the cytoplasmic level, this is an indicator of the good quality 
of our system.  
Among these putative interactors no specific proteins with NBD properties were found and 
therefore we focused our attention on FieF. This protein is a member of the Cation Diffusion 
Facilitator (CDF) family of metal transporters and is involved in zinc detoxification through the 
efflux from the bacterial cell, together with another member of the CDF family, ZitB, and with the 
P-type ATPase ZntA (Paulsen and Saier, 1997; Grass et al., 2001).  
Despite this protein is apparently engaged in a different function from that of SbmA, we showed 
that the deletion of its gene affected the uptake of Bac7 producing a reduction in the amount of 
internalized peptide, an effect that was completely reversed by the complementation of the 
mutation.  
The capability of FieF encoded by a plasmid to restore the normal level of uptake was strictly 
dependent on the presence of SbmA. These results strongly support the existence of an interaction 
between SbmA and FieF and suggest that FieF is involved in the SbmA-mediated uptake of 
substrates, such as Bac7(1-35), even if the mechanistic understanding of this interaction remains 
elusive.  
It may be that zinc efflux due to FieF activity could regulate the uptake of peptides throughout 
SbmA. In this case SbmA activity depends on the zinc concentration by mean of the binding to 
FieF, or SbmA may be a zinc sensor itself. This observation is also supported by the results of 
isothermal titration calorimetry (ITC) analysis, indicating that purified SbmA is able to bind zinc 
ions, even if at a lower affinity than that of FieF.  
Since FieF is an efflux pump involved in zinc detoxification and we demonstrated here that SbmA 
expression is induced by toxic concentrations of zinc, an alternative hypothesis consists of a mutual 
regulation between the two proteins to maintain zinc homeostasis, a function which may depend on, 
or be modulated by, the presence of an unidentified peptide substrate for SbmA (similar to Bac7).  
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Ultimately, the mechanism by which these two proteins co-operate and their overall function needs 
still to be elucidated and will be the object of further studies.  
As many others metal ions-efflux systems, the expression of fieF is regulated by the intracellular 
metal concentration (Grass et al., 2001). We found that increasing concentrations of ZnCl2 strongly 
induce also the expression of SbmA, both at the transcriptional and translational level.  
Since sbmA promoter is known to be under the control of the extracytoplasmic stress sigma E 
regulator, and this transcriptional factor is also activated by metals, such as copper and zinc (Egler 
et al., 2005), we checked whether the induction of the sbmA gene is mediated exclusively by RpoE.  
We confirmed that the zinc-dependent SbmA overexpression is RpoE-dependent and also that the 
expression of the protein increases during the stationary phase. Unexpectedly we found that ZnCl2 
upregulates SbmA expression also in the absence of RpoE, suggesting the presence of a second 
RpoE-independent mechanism of regulation. In the latter case the concentration of Zn(II) required 
for the induction is higher with respect to the RpoE-mediated induction, and it is active only during 
the exponential growth phase. This mechanism seems to be inactive during the stationary phase and 
may become important to increase the expression of SbmA during the growth phase of the cells, 
when RpoE is not fully activated. Further studies will be necessary to clarify the meaning of this 
regulation.  
The consequence of the upregulation of SbmA is an increased uptake of and susceptibility to the 
peptide. This result may have a physiological relevance: changing the Zn(II) concentration in the 
host could regulate the sensitivity of the target bacteria to the proline-rich peptides or other 
effectors.  
Intracellular Zn(II) levels were found to be high in mast cell granules (Ho et al., 2004), airway 
epithelial cells (Truong-Tran et al., 2000), in the intracellular and extracellular matrix and to 
accumulate in skin tissues following injury (Lansdown et al., 2007). Moreover, zinc has been 
shown to play an important role in the innate host defence by mediating the activation of human 
neutrophils and mast cells (Freitas et al., 2010; Fukada et al., 2011). Fukada et al. highlighted in 
mast cells a zinc signalling system (Fukada et al., 2011; Hirano et al., 2008) characterized by a “Zn 
wave” phenomenon in which Zn(II) levels change within minutes through the release of free zinc 
from the ER (Yamasaki et al., 2007). Freitas et al. clearly showed that oxidative burst in neutrophils 
was activated at concentrations of zinc ranging from 0.25 to 1 mM in vitro via activation of protein 
kinase C (PKC) (Freitas et al., 2010).  
In this context, the overexpression of SbmA induced by increasing concentrations of Zn(II), which 
correspond to those showed to be responsible for the neutrophils’ activation, may be exploited by 
the innate immune system to render the Gram negative bacteria more susceptible to proline-rich 
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antimicrobial peptides and likely other AMPs. In addition, the zinc-mediated SbmA overexpression 
may be part of a cellular pathway activated by the bacteria to signal they have reached the host 
compartments and to trigger some specific processes useful for their virulence and invasion 
properties.  
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6. CONCLUSIONS 
SbmA/BacA is an inner membrane protein of the Gram negative bacteria likely involved in the 
uptake of peptides and essential for the chronic infection of the host. 
The present work highlights some functional and architectural aspects of SbmA in E. coli. Results 
indicate that SbmA is evolutionary linked to the widespread ABC transporters but that during its 
evolution it has likely lost some typical features of this transport systems such as the ATP binding 
domain and the request of a substrate-binding protein. In this manner the current and functional 
form of SbmA corresponds to an atypical transporter which maintains a dimeric transmembrane 
domain (TMD), hallmark of ABC complexes. Transport of substrates, such as Bac7(1-35), in the 
absence of an ATP binding domain, seems to be driven by the electrochemical gradient rather than 
by ATP hydrolysis, a shift in the source of energy which has been already observed previously in 
other uncompleted systems.  
SbmA expression is strongly modulated by zinc ions in a complex manner suggesting a stress role 
for this protein in bacteria. The observed interaction between this protein and the zinc efflux pump 
FieF point to a possible involvement of SbmA in zinc detoxification, a function which may be 
modulated by the binding of an unidentified peptide substrate to SbmA. Alternatively, the 
contribution of FieF in the SbmA-mediated internalization of Bac7 suggests that zinc efflux through 
FieF could regulate the uptake of peptides by SbmA. 
The regulation of the expression of SbmA by high concentrations of ZnCl2 might have a 
physiological relevance in the host because it makes the target bacteria more susceptible to the 
AMPs, at least the proline-rich family, and at the same time it activates cellular effectors such as the 
neutrophils.  
This work prompted us to further investigate the relationship between SbmA and the zinc efflux 
pump FieF, and open a new scenario on the role of this protein with respect to the antimicrobial 
peptides and the immune system. In addition, these insights on the functioning of this membrane 
protein might be important to design novel antibiotic molecules that exploit this way to enter the 
target bacteria.  
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